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CHAPTER I 
INTRODUCTION 
In vertebrates four major systems of intercellular 
communication exist: the neural, the endocrine, the 
neuroendocrine, and the immune systems. For many years, 
evidence has accumulated linking the neural, the endocrine, 
and the neuroendocrine systems, but the immune system was 
often viewed as essentially autonomous (Bateman et al., 
1989). Current investigations, however, reveal information 
as to how the immune system is able to communicate with 
other systems. Evidence delineating the structural and 
functional connections between the central nervous system 
and the immune system has propelled research in this area to 
unprecedented expansion (Arnason, 1991; Harbour-McMenamin et 
al., 1986; Hiestand et al., 1986; Smith et al., 1982; Smith 
and Blalock, 1981) . Identification of shared informational 
molecules such as cytokines, hormones, and neuropeptides 
provides molecular evidence for bidirectional communication 
2 
between these systems (Arnason, 1991; Carr and Blalock, 
1991) . One limb of this bidirectional communication may 
occur through the cytokines tumor necrosis factor-a, 
interleukin-1, and interleukin-6, which have all been shown 
to be potent modulators of the hypothalamic-pituitary-
adrenal axis. More specifically, interleukin-1 has been 
shown to enhance sympathetic nerve activity (Haefli et al, 
1993; Ichijo et al., 1994), modify the neuronal gene 
expression of molecules such as substance P (Jonakait, 
1993), and is synthesized and released by cultured 
sympathetic neurons (Frieden et al, 1992). Studies indicate 
that immune-derived peptides may also play a role in 
modulating neural/endocrine function. In 1981, Blalock and 
Smith reported that human peripheral blood lymphocytes (PBL) 
infected with Newcastle disease virus (NDV) produced the 
proopiomelanocortin (POMC)-derived peptides, 
adrenocorticotropin (ACTH) and Beta-endorphin (Smith and 
Blalock, 1981) . Interestingly, in studies with mice 
previously hypophysectomized to eliminate the pituitary as 
asource of ACTH, challenge with NDV significantly elevated 
plasma corticosterone levels (Smith et al., 1982). 
Furthermore, glucocorticoids released in response to 
3 
immunoreactive-ACTH were shown to negatively feedback on the 
immune cells to prevent further release of ACTH or 
endorphin. Thus, products of the immune system were found to 
affect output from the adrenal cortex. 
More recent investigations have vastly expanded the 
list of peptide signalling molecules found to be synthesized 
and released by activated immune cells. These peptides 
include but are not limited to thyrotropin (TSH) (Smith et 
al., 1983), chorionic gonadotropin (CG) (Harbour-McMenamin 
et al., 1986), growth hormone (GH) and prolactin-related 
peptides (Hiestand et al., 1986). Evidence suggests that 
these peptides may serve an autocrine/paracrine function 
with cells of the immune system in addition to the 
traditional axes (Plaut, 1987). Preliminary studies 
suggest that there is yet another peptide of immune origin 
which, in contrast to those mentioned above, is able to 
stimulate catecholamine release from the adrenal medulla 
(Jones et al., 1993; Wang, 1993). Furthermore, preliminary 
experimental evidence in preparation for this dissertation 
work indicated that known peptide chromaff in cell 
secretagogues are not responsible for the observed 
phenomena. Such peptides include vasoactive intestinal 
4 
peptide (VIP), bradykinin, angiotensin II, and pituitary 
adenylyl cyclase activating polypeptide (PACAP) (Isobe, 
1993; Livett and Marley, 1993; Marley, 1987), This 
previously uncharacterized peptide has also been shown to 
cause epinephrine secretion comparable to maximal neural 
stimulation but at an attenuated rate. Based on preliminary 
studies from this (Jones et al., 1993; Wang, 1993; Zhou and 
Jones, 1993) and other laboratories (Seidler and Mills, 
1989) and the lymphoid-adrenal cortical interaction 
demonstrated by Smith and Blalock, a lymphoid-medullary 
interaction through a yet undescribed lymphocyte product is 
not surprising. 
A variety of stressors, both physiologic and 
psychologic, activate a cascade of events which leads to the 
release of glucocorticoids and catecholamines from the 
adrenal gland by both neural and hormonal stimulations. The 
catecholamines, epinephrine and norepinephrine, are pivotal 
regulators of many physiologic events in man and have been 
shown to be potent modulators of the immune response. 
Immune cells have been shown to express both functional 
beta-2 (Krieger, 1983; Plaut, 1987) as well as alpha-1 
adrenoreceptors (Sanders and Munson, 1985) which account for 
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the well-documented direct action of catecholamine on immune 
function (Malec et al., 1985; Mihran-Davis et al, 1991; 
Murray et al., 1993; Rinner et al., 1992). Catecholamine 
action on immune cells has long been viewed as being 
suppressive. This suppressive action ranges from decreases 
in T helper/T suppressor cell number ratio (Malec et al., 
1989) to an inhibition of natural killer cell cytotoxicity 
(Whalen and Bankhurst, 1990). Interestingly, current 
literature indicates that catecholamine action may also act 
to enhance the immune response (Arnason, 1991) . Data 
indicate that not only stress itself, but characteristics of 
the stressor such as duration (acute/chronic) and 
intensity/severity are also important variables modulating 
stress-induced immunologic alterations. For example, the 
same stressor can have a positive or negative relationship 
with immune responses depending on the intensity, such that 
less severe or acute stressors correlate with enhanced 
immune response, while potent/chronic stressors seem to 
correlate with depressed immunologic response (Rinner et 
al. I 1992) • Such immunoenhancement may serve to protect 
individuals for short periods of stress. Ultimately, 
chronic stress, such as that associated with long term 
illness, and subsequent maintained elevations in plasma 
catecholamine appears to result in the well documented 
immunocompromising aspects of the stress response (Sanders 
and Munson, 1985) . To date there have been no successful 
therapeutic approaches to control stress-induced 
immunosuppression. Identifying immune-derived signal 
6 
molecule(s) that modulate stress hormone release may lead to 
therapeutic manipulation by suppressing or enhancing 
bioactive peptide release and/or activity. 
This dissertation research has built upon previous 
studies which presented evidence for the non-neurogenic 
stimulation of adrenal medullary catecholamine release. 
Zhou and Jones (1993) demonstrated in conscious adrenal 
denervated rats that plasma epinephrine levels were 
significantly elevated 90 minutes after bacterial endotoxin 
challenge. This epinephrine elevation was approximately 
one-third that observed in non-denervated endotoxin 
challenged rats suggesting that a non-neural mechanism may 
comprise part of medullary epinephrine release. Related 
findings have been reported in newborn rats. Ganglionic 
blockade in endotoxin-challenged newborn animals was unable 
to prevent a rise in plasma catecholamine also suggesting a 
non-neurogenic stimulation of adrenal medullary 
catecholamine release (Seidler and Mills, 1989). In vitro 
experiments have demonstrated that factor(s) released by 
immune cells may potentially act in vivo to modulate 
medullary catecholamine release (Jones et al, 1993; Wang, 
7 
1993) . Experimental evidence indicates that these factor(s) 
are small molecular weight peptide(s) (<3,000) and are 
present and active in a variety of species (bovine, porcine, 
human) . 
Considering the clinical importance of stress-induced 
immunosuppression and the potential ramifications of 
immunomodulation of the stress response, understanding the 
role of various immune-derived signalling molecules in this 
process may provide pivotal information and a basis for 
future therapeutic intervention. This dissertation project 
was designed to begin to elucidate the components of the 
immune system which may play an role in communication 
between the immune system and the neuroendocrine system via 
the adrenal medulla. The hypothesis is that mononuclear 
cells release a novel bioactive peptide which stimulates 
adrenal medullary secretion in a calcium-dependent manner. 
The specific aims of the following studies include: 1) the 
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characterization of peptide-mediated secretion with an 
emphasis on the role of calcium in peptide-induced 
exocytosis, 2) the identification of the specific 
mononuclear cell subset(s) involved in release of the 
bioactive peptide and assessment of feedback inhibition by 
epinephrine on further peptide release, 3) the further 
isolation and characterization of this bioactive peptide 
using molecular biological and immunological techniques, and 
4) the examination of the potential significance of this 
peptide in endotoxicosis and related shock states. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
A. The Catecholamines 
I. Physiologic Role in the Stress Response 
The catecholamines, epinephrine and norepinephrine, are 
pivotal regulators of many physiological events in man. 
Increased circulating levels of catecholamine are known to 
mediate arteriolar constriction, elevation of blood glucose 
and free fatty acids, as well as positive chronotropic and 
inotropic effects. In 1929, Walter Cannon first associated 
these and other physiologic changes with increased 
circulating catecholamine in his discussion of a 
phenomenology referred to as the "fight or flight" response. 
This reaction occurs when animals, including man, perceive 
danger (cognitive stimuli) and prepares the animal to 
respond to the threat through either direct conflict 
("fight") or escape ("flight") . An increased level of 
9 
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circulating catecholamine, however, is also mediated by 
stimuli not recognized by the cerebral cortex (non-cognitive 
stimuli) . Examples of non-cognitive stimuli include 
bacteria, tumors, and viruses. Thus, both psychological and 
physiological stimuli can evoke a classic stress response. 
Documented actions of the catecholamines have been 
classified into four broad categories which include: 1) a 
peripheral excitatory action on certain smooth muscle types 
(i.e. blood vessels of the skin, mucous membranes) and on 
some sweat and salivary glands; 2) a peripheral inhibitory 
action on other types of smooth muscle (i.e. gut wall, 
bronchial tree); 3) a cardiac excitatory action responsible 
for positive chronotropic and inotropic effects; and 4) 
metabolic actions such as glycogenolysis and lipolysis. 
More recent investigations, however, have expanded this 
list of adrenergic actions to include modulation of immune 
function. The mechanisms and potential implications of this 
neuroendocrine-immune interaction are just beginning to be 
understood. 
II. Sources and Secretion of the Catecholamines 
The major sites of release of the catecholamines are 
11 
the postganglionic efferent sympathetic terminals and the 
adrenal gland. The adrenal gland, located in the abdominal 
cavity rostral to the kidneys, consists of two anatomically 
and embryologically distinct structures - the outer cortex 
and the inner medulla. While the glucocorticoid-secreting 
cortex is of mesodermal origin, the inner medulla, source of 
the catecholamines, is of neuroectodermal origin. During 
embryonic development, under influence of the 
corticosteroids, the sympathoadrenal progenitor cells of the 
neural crest migrate to the adrenal medullary cavity and 
differentiate into chromaffin cells (Anderson and Axel, 
1986) . Upon settling in the adrenal gland, the chromaffin 
cells are innervated by preganglionic sympathetic neurons of 
the splanchnic nerves and become part of the sympathetic 
nervous system. 
These adrenal medullary chromaffin cells synthesize, 
store and secrete catecholamines in response to a variety of 
stimuli. While the list of chromaffin cell secretagogues 
has expanded, Feldberg et al. (1934) were the first to 
document that the release of acetylcholine from the 
splanchnic nerve was the immediate neurologic stimulus that 
induced adrenal medullary catecholamine secretion. This 
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group observed that stimulation of the splanchnic nerve led 
to the appearance of acetylcholine (ACh) in the blood of the 
feline adrenal vein and, ultimately, catecholamine 
(adrenaline/epinephrine) secretion from the adrenal gland. 
Furthermore, Feldberg and colleagues demonstrated both 
muscarinic and nicotinic agonists could stimulate 
catecholamine secretion indicating the presence of both 
cholinergic receptor types on chromaffin cells. 
Depending on the animal model, activation of either the 
nicotinic or the muscarinic receptor can lead to chromaff in 
cell catecholamine secretion (Wakade and Wakade, 1983). 
Although knowledge of the exact mechanism of chromaffin cell 
exocytosis is poorly understood, one common feature of all 
models is that catecholamine secretion is dependent on an 
increase in intracellular calcium. The source of this 
calcium may be from internal stores, as is the case with 
muscarinic receptor stimulation, or from the influx of 
extracellular calcium, as with nicotinic receptor 
activation. Muscarinic receptor activation, the sole 
stimulus for chick adrenal medullary catecholamine secretion 
(Douglas, 1975) and non-functional in bovine chromaffin 
cells (Cheek and Thastrup, 1989), leads to the liberation of 
diacylglycerol (DAG) and inositol trisphosphate (IP3 ) from 
membrane phosphatidylinositols (phosphatidylinositol 
bisphosphate, PIP2 ). The liberated IP3 then binds to its 
intracellular receptor and, ultimately, stimulates calcium 
release from internal stores. Interestingly, chromaffin 
13 
cells appear to possess two different, spatially distinct 
intracellular calcium stores - an IP3 sensitive store and a 
caffeine sensitive store (Burgoyne et al., 1989). In bovine 
chromaffin cells, evidence indicates that the caffeine 
sensitive store is involved in calcium homeostasis rather 
than exocytosis (Cheek et al., 1990). 
Unlike muscarinic receptor activation, the 
catecholamine secretion in response to nicotinic receptor 
stimulation requires the availability of extracellular 
calcium. Activation of nicotinic receptors is functionally 
important in cat (Douglas, 1975), dog (Tsujimoto and 
Ashidawa, 1975), and rat (Yoshizaki, 1973) and is the sole 
cholinergic stimulus for bovine chromaf fin cell 
catecholamine secretion (Cheek et al., 1989). Nicotinic 
receptor activation increases cation conductance through the 
nicotinic receptor cation channel. The influx of cations, 
predominantly sodium, depolarizes the chromaff in cell and 
14 
activates voltage-gated sodium and calcium channels further 
depolarizing cells. The depolarization activates additional 
voltage-gated calcium channels which is followed by 
increased calcium influx through these channels. This 
increased intracellular calcium then triggers catecholamine 
secretion. 
In addition to nicotinic and muscarinic receptor 
activation, chromaffin cell catecholamine secretion can also 
be induced by depolarizing concentrations of extracellular 
potassium. Such depolarization immediately activates 
voltage-dependent calcium channels thereby promoting calcium 
influx and subsequent catecholamine secretion. Thus, 
secretion in response to extracellular K+, like nicotine-
induced secretion, is dependent on extracellular calcium. 
Further research with bovine chromaffin cells has indicated 
that calcium influx from extracellular sources is also 
essential for catecholamine secretion in response to other 
known chromaffin cell secretagogues (Cheek,1991). 
15 
B. Effects of the Catecholamines on Immune Cell Function 
I. Stress and Illness 
The role of stress in illness has been debated for many 
years. Although numerous observations have been documented 
over the centuries which note a relationship between 
stressful periods in life and subsequent illnesses, 
definitive physiologic evidence of such a relationship has 
been difficult to obtain since both psychological 
(cognitive) and physical (non-cognitive) stimuli may 
contribute to physiologic stress. The idea that mental and 
physical health are interdependent can be found in early 
medicine in the works of Aristotle. This concept was 
further substantiated by Galen when he observed that 
melancholic women were more likely to develop cancer than 
their more confident and vital counterparts (Kort, 1994). 
Similar associations between emotional stress and health 
appear even in current studies. For instance, studies cite 
that job strain has a negative impact on health (Lerner et 
al., 1994). There is also evidence of a correlation between 
a positive mental state and better health in terminal AIDS 
patients (Kendall, 1994). 
Early in this century Hans Selye expanded this notion 
of "mind-body" interaction when he noted that not only 
emotional stress but also physical stress may affect 
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physiologic function. Selye described how "diverse noxious 
agents" produced nonspecific events that "sick people" share 
in common. Furthermore, Seyle explained that these "noxious 
agents" included both harmful physical agents (i.e. viruses, 
bacteria, excessive body weight) as well as how an 
individual reacted to a harmful physical agent (cognitive 
stimuli) (Selye, 1936). 
One of the many difficulties in ascertaining a 
potential connection between stress and illness is in the 
definition of "stress". Unfortunately, as Selye would note, 
there is no reliable or accurate way to experimentally 
define stress or how it will affect an individual since not 
only the stressor itself but also the way an individual 
reacts to that stressor will effect the physiologic response 
(Selye, 1975). Typically, the term "stress" is defined in 
the context of research and pathophysiology as "the 
reactions of the body to forces of a deleterious nature, 
infections and various abnormal states that tend to disturb 
its normal physiological equilibrium (homeostasis)" 
17 
(Burgess, 1987). As Selye described in his early 
observations, this definition requires that the reactions of 
the body to physical/psychological stimuli as well as the 
stimuli themselves be considered the "stress". This is 
problematic when designing experimental protocols to 
determine the stress-illness relationship since both 
physical and psychological parameters are involved (Selye, 
1980). Fortunately, experiments in animals as well as in 
humans indicate that the mechanism behind both physiological 
and psychological stress-induced dyshomeostasis may be 
attributed mostly to changes in the neuroendocrine system 
which modulates immune system function (Sheridan et al. 
1994). Key factors of this neuroendocrine immunomodulation 
appear to be the pituitary and adrenal gland hormones, 
including the catecholamines. 
II. Sympathetic Innervation of Primary and Secondary 
Lymphoid Organs 
Investigations have demonstrated that adrenergic 
modulation of the immune system may occur at the earliest 
stages of the immune cell maturation process and may 
potentially dictate the functional capacity of immune cell 
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populations. Anatomical studies from several laboratories 
(Ackerman et al., 1987; Bellinger et al., 1988; Kendall and 
Al-Shawaff, 1991; Nohr and Weihe, 1991) show that autonomic 
nerve fibers, mainly noradrenergic, innervate primary, 
secondary as well as mucosal associated lymphoid tissue -
organs which are the ultimate source of all cells of the 
immune system. These tissues include the bone marrow, 
thymus, spleen, lymph nodes and gut-associated lymphoid 
tissue (GALT) Distributed into specific compartments of 
these organs, these noradrenergic fibers are associated with 
various cellular components of the immune system including 
lymphocytes, macrophages, and mast cells (Felten and 
Olschowka, 1987; Felten and Felten, 1990) 
Developmental studies of the noradrenergic innervation 
of lymphoid organs of the rat indicate that this 
sympathetic-immune association may occur post-gestationally 
and continue into adulthood (Ackerman et al., 1987; D.L. 
Felten et al., 1987). As the animals mature, however, there 
appears to be an age-dependent denervation of the spleen 
such that by age 27 months the total norepinephrine content 
of the rat spleen diminished by approximately 50% (S.Y. 
Felten et al., 1987; Bellinger et al., 1987). While this 
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diminished splenic norepinephrine content could be explained 
by decreased synthesis in existing splenic nerve terminals, 
further investigations indicated there was an actual 
retraction and loss of noradrenergic fibers in the aging 
spleen. Interestingly, sympathetic innervation in other 
organs of these aged animals, such as the heart, persisted 
and circulating catecholamine actually increased with age. 
The functional role of noradrenergic innervation of 
lymphoid organs has yet to be fully understood. Studies 
examining central lymphoid compartments, the bone marrow and 
thymus, indicate that cell proliferation, differentiation, 
and emigration may be influenced by the local branches of 
the sympathetic nervous system (Webber et al., 1970; Byron, 
1972, Singh, 1985). For instance, the catecholamines may 
inhibit hematopoiesis via alpha-1 adrenergic receptors on 
bone marrow cells (Maestroni and Conti, 1994). The effects 
of noradrenergic innervation on secondary lymphoid 
compartments, although more thoroughly examined, appear 
dependent on the animal model and experimental protocol. 
Several early studies (Besedovsky et al., 1979; Williams et 
al., 1981) suggested that the immune system was 
constitutively suppressed by noradrenergic innervation of 
the secondary lymphoid organs. Chemical or surgical 
sympathectomy of the secondary lymphoid organs in these 
studies led to an augmentation of immunologic functions 
suchas the antibody (Besedovsky et al., 1979) and the 
delayed hypersensitivity response (Braun et al., 1986) 
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These investigations, however, utilized neonatal mice or 
rats and assessed immune cell function in these same animals 
after they reached adulthood. Interestingly, if the 
sympathectomy was not performed until the animal reached 
adulthood, the antibody response was either inhibited (Hall 
et al., 1982) or unaffected (Miles et al., 1981). Unlike 
earlier studies, these data suggested that in the adult 
animal the sympathetic nervous system maintained immune cell 
function in the secondary lymphoid organs. Although 
sympathectomy of the adult animal has been shown to suppress 
both T cell (Livnat, 1986; Madden et al., 1986) and B cell 
(Madden et al., 1986) function, natural killer cell and 
macrophage activity appears to be augmented when 
noradrenergic influences are removed from lymphoid organs 
(Koff et al., 1985; Madden et al., 1987). The variability 
of the noradrenergic influence on lymphoid function (i.e. 
age, organ/cell type) makes it difficult to designate 
specific immunologic consequences to alterations in this 
neural-immune interaction at even the earliest stages of 
immune cell development. 
III. Inunune Cell Adrenoreceptors 
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The catecholamines exert their effects through two main 
classes of adrenergic receptors, a and ~ - a subdivision 
first proposed by Ahlquist (1948) to distinguish different 
adrenergic responses in various organ systems. Later 
studies (Arnold et al., 1966; Lands et al., 1967; Lager, 
1974) revealed there are several different subtypes of each 
of these receptors, each appearing to be the product of a 
distinct gene family (Summers and McMartin, 1993). Subtypes 
of the beta subclass include type-1, type-2, and more 
recently the type-3 beta adrenoreceptor. Alpha adrenergic 
receptors are divided into type-1 and type-2 (Price et al., 
1994). 
The second messenger systems to which the adrenergic 
receptors are coupled are unique to each subtype. However, 
all sequenced adrenergic receptors have been shown to belong 
to the guanine nucleotide binding protein, or G-protein, 
linked superfamily of receptors (Cotecchia et al., 1990; 
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Strosberg, 1991). The a 1 -adrenoreceptor, through Gq, 
stimulates phospholipase C (PLC) which initiates the 
hydrolysis of phosphatidylinositol bisphosphate (PIP2 ) to 
produce the second messengers diacylglycerol (DAG) and 
inositol trisphosphate (IP3 ). These second messengers are 
responsible for the activation of protein kinase C (PKC) and 
the liberation of calcium from intracellular stores 
respectively (Berridge and Irvine, 1989) . In contrast, the 
a 2 -adrenoreceptor is coupled by Gi to adenylyl cyclase or to 
ion channels. Activation of the a 2 -receptor alters cellular 
activity by reducing intracellular adenosine 3', 5' - cyclic 
monophosphate (cAMP) or by directly modifying ion channel 
activity (e.g. Ca2 + or K+ channels) (Bylund, 1988). The 13-
adrenoreceptor subtypes are coupled through yet another G 
protein, G8 , to the membrane bound enzyme, adenylyl cyclase. 
Hence, 13-adrenergic receptor activation alters cellular 
activity by increasing intracellular cAMP concentrations. 
Characteristically, a receptors are more sensitive to 
norepinephrine while the 13 receptor subtype is more 
responsive to epinephrine stimulation (Goodman and Gilman, 
1990). Similarly, the adrenergic blocking action of many 
compounds is also selective for each receptor type. The 
imidazolines and haloalkylamines are selective for the a 
receptors whereas propranolol blocks only ~ receptors 
(Goodman and Gilman, 1990). More recently, compounds 
specific to receptor subtypes have been identified. For 
23 
example, salbutamol and salmeterol are specific ~2 -receptor 
agonists while alpha-methylnorepinephrine stimulates the 
alpha-2 adrenoreceptor alone (Felsner et al., 1995; Muller-
Wieland et al., 1994). The unique pharmacologic properties 
of these compounds make it possible to experimentally 
ascertain which adrenergic receptor type(s) are responsible 
for individual cellular or systemic alterations in response 
to catecholamine. Such pharmacologic agents were also 
utilized to determine that cells of the immune system 
possess functional alpha and beta adrenergic receptors and 
are capable of responding to catecholamine. 
A. Beta Adrenergic Modulation of Immune Cell Function 
The ~-adrenergic receptor function has been well 
characterized due to the availability of several high 
affinity labelled antagonists. Radioligand binding and 
pharmacologic studies have confirmed the presence of the ~ 2 -
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adrenergic receptor on most cells of immune origin. Cell 
types expressing functional 02 -receptors include 
granulocytes, natural killer cells, monocytes, B cells, and 
T cells (Plaut, 1987). There is some discrepancy in the 
literature as to which of these cell populations have the 
highest receptor density. Some sources demonstrate the T 
suppressor/cytotoxic (CDS+ phenotype) and the natural killer 
cell populations as having the most 02 -adrenoreceptors 
(Murray et al., 1992) while others the B-cell population 
(Arnason, 1991) . 
The immunosuppressive properties of 02 -receptor 
activation were first demonstrated using human peripheral 
blood lymphocytes (PBL) co-cultured with high concentrations 
of the 0-adrenergic agonists isoproterenol and epinephrine 
(25 mM) . Culture of these cells in the presence of the 0-
agonists led to suppressed mitogen responsiveness (Hadden et 
al., 1970). Even in the presence of a low, physiologically 
relevant concentrations (1-lOOnM), addition of isoproterenol 
for a brief period at the initiation or the end of the 
culture period resulted in depressed response to the 
mitogen. Conversely, in vitro studies demonstrated that 
mitogenic stimulation led to a down-regulation of the 0-
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receptor on lymphocytes (Smith et al., 1971; Johnson et al., 
1981; Cazaux et al., 1995). Among other actions, ~­
adrenergic agonists have also been shown to suppress IL-2 
production, block expression of IL-2 receptors, inhibit T 
cell mediated proliferation, inhibit lymphocyte-mediated 
toxicity as well as human lung mast cell function, and 
depress NK cell function (Feldman et al., 1987; Plaut, 1987; 
Heilig et al., 1993; Benschop et al., 1994; Chong et al., 
1995). ~ 2 -adrenoreceptor activation has also been shown to 
alter metabolic pathways in mononuclear leukocytes by 
inhibiting fatty acid synthesis (Muller-Wieland et al., 
1994) . In support of this suppressive property of the ~ 2 -
adrenergic receptor, experimental evidence demonstrates that 
~-receptor antagonists tend to potentiate the 
immune response (Luecken and Lysle, 1992; Benschop et al., 
1993; Gentilini et al., 1994). 
While a trend emerges which indicates ~-receptor 
activation suppresses immune cell function, the literature 
reveals this relationship is dependent on the cell 
population being studied and the experimental conditions. 
For instance, whereas T cytotoxic/suppressor cell function 
is depressed by ~-receptor activation, Leu 3+8+ (Th 
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suppressor activator) cells responsiveness to PHA is 
enhanced in the presence of isoproterenol (10 µM) while Leu 
3+8- (Th suppressor enhancer) cells are not effected (Khan 
et al., 1985). Therefore, one may not generalize that cell 
mediated immunity is inhibited by ~-adrenergic receptor 
activation. Interestingly, the humoral immune response also 
may be enhanced by ~-adrenergic receptor activation. ~ 2 -
adrenergic receptor activation has been shown to lead to an 
enhanced antibody response (Burchiel and Melman, 1979; 
Sanders and Munson, 1984a; Sanders and Munson, 1984b) 
through both direct and indirect mechanisms. 
Investigations are addressing the role of immune cell 
~-adrenergic receptor activation in disease states such as 
juvenile type I diabetes mellitus (Schwab et al., 1993) or 
schizophrenia (Bondy et al., 1984) These studies 
demonstrate a decreased ~-receptor responsiveness in the 
disease states. This is attributed to a diminished receptor 
density on the lymphocytes of diabetic children and a 
decreased receptor affinity in schizophrenic patients. In 
vitro models may potentially provide some insight into the 
mechanisms behind altered ~-receptor responsiveness in 
these or other disease states. However, the literature 
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clearly demonstrates that to understand the clinical 
implications of disease-related diminished immune cell ~­
receptor responsiveness, variables such as the cell 
population(s) exhibiting the diminished response need to be 
considered. 
B. Alpha Adrenergic Modulation of Immune Cell Function 
Pharmacologic and radioligand binding studies 
demonstrate that both the a 1 - and the a 2 -adrenoreceptor are 
present on cells of immune origin. Leukocytes which have 
been shown to express functional a-adrenergic receptors 
include T cells (Felsner et al., 1995), monocytes (Lappin 
and Whaley, 1982), neoplastic (chronic lymphocytic leukemia) 
B cells (Goin et al., 1991), and neutrophils (Hulin et al., 
1985), although neutrophil expression of this receptor 
subtype has recently been brought into question (Musgrave 
and Seifert, 1994). Further examination of leukocyte a-
adrenoreceptor expression reveals that this receptor may not 
only differ among cell types but also may vary within a 
single cell population depending on its anatomical location. 
Experimental evidence demonstrates that while the alpha-
receptor is present on splenic lymphocytes (McPherson and 
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Summers, 1982), there is no evidence that the receptors are 
found on the circulating counterparts of these cells (Casale 
and Laliner, 1988). 
The potential role of a-adrenergic receptor in 
modulation of immune cell function is just beginning to be 
understood. Several studies have employed a-adrenergic 
agonists and antagonists to determine the function of this 
receptor type in stress-induced immunomodulation (Hadden et 
al., 1979; Sanders and Munson, 1985). Some of the earliest 
work from Hadden et al. (1979) demonstrated that like 
epinephrine, high concentrations of norepinephrine (25 mM) 
in culture with human peripheral blood lymphocytes (PBL) led 
to an immune cell suppression. Interestingly, unlike the 
immunosuppressive ~-receptor modulated response, more 
physiologic concentrations of norepinephrine (1-lOOnM) 
elicited an increased mitogen responsiveness in the cultured 
cells. Similar to the epinephrine-mediated ~-response, the 
time and duration of exposure of the lymphocytes to the 
norepinephrine was important. Recent investigations show 
that this a-adrenergic immunopotentiating effect of the 
catecholamines may apply to the in vivo scenario as well. 
Carr et al. (1992) have demonstrated that in the mouse 
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model, cold stress consistently augmented total IgG and IgM 
production by splenic lymphocytes and this mediation was a 
result of activation of alpha-adrenergic pathways. However, 
since splenic lymphocytes were utilized in these studies, it 
is unclear which cell population(s) are responsible for this 
a-receptor mediated augmentation. 
Much like ~-adrenergic receptor, a-receptor activation 
not only has immunopotentiating (i.e. enhanced antibody 
response) but also immunosuppressive capabilities. 
Recently, Felsner et al. demonstrated that a 20h continuous 
treatment of rats with catecholamine markedly suppressed the 
in vitro reactivity of T lymphocytes. Using selective 
agonists, the group identified the relevant receptor to 
belong to the alpha-2 subtype (Felsner et al., 1995). 
Contrary to other experimental findings, Felsner and 
colleagues observed this alpha-mediated suppression on T 
cells isolated from peripheral blood but not in splenic T 
cells. This suggests that peripheral blood lymphocytes do 
possess functional alpha-adrenoreceptors. The suppressive 
action of alpha-adrenergic receptor activation is also 
prevalent when looking at metabolic pathways in mononuclear 
leukocytes. Muller-Wieland et al. (1994) demonstrated that 
the specific alpha-2 receptor agonist alpha-
methylnorepinephrine, but not the alpha-1 agonist 
phenylephrine, inhibited the fatty acid synthesis rate in 
isolated human mononuclear cells. 
C. Immunomodulation of Neuroendocrine Function 
I. Immune Cell Secretion of Neuroendocrine Signalling 
Molecules 
A salient feature of immune system and neuroendocrine 
system interactions is their capacity to communicate with 
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each other via common signal molecules and common receptors 
(Blalock, 1994). Central to this bidirectional 
communication is production of classic neuropeptide hormones 
by cells of immune origin. The first evidence that 
leukocytes could synthesize functional neuroendocrine 
hormones was obtained from studies which demonstrated that 
during the production of interferon alpha (IFNa), virally-
challenged human leukocytes coexpressed a peptide which was 
antigenically related to the pituitary hormone, 
adrenocorticotropin (ACTH) (Smith and Blalock ,1981) This 
immune-derived ACTH was similar to its pituitary counterpart 
with respect to its antigenicity, molecular weight, and 
retention time on high pressure liquid chromatography 
(HPLC) . Furthermore, the leukocyte-derived ACTH could 
stimulate glucocorticoid secretion from adrenal cortical 
cells in vitro and, thus, was bioactive and potentially 
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functional (Clarke et al., 1993). The potential biological 
relevance of this molecule was addressed in in vivo studies 
using hypophysectomized mice. Viral challenge of 
hypophysectomized animals led to a significant elevation in 
circulating glucocorticoids when compared to control mice 
even though the classic glucocorticoid stimulant, pituitary 
ACTH, was essentially eliminated. Splenocytes of these 
hypophysectomized mice also stained positive for both ACTH 
and additional POMC-derived peptides, the endorphins, while 
control mouse splenocytes did not (Smith et al., 1982). 
Ultimately, researchers demonstrated that this leukocyte-
derived ACTH had the same amino acid sequence as pituitary-
derived ACTH and originated from the same precursor, 
proopiomelanocortin (POMC), in immune cells as in the 
pituitary gland (Smith et al., 1990). 
While immune cell production of the POMC-peptides was 
originally described in response to immunologic stimulation 
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of these cells, later studies revealed that immune cells 
synthesize and secrete bioactive ACTH and endorphin in 
response to corticotropin releasing hormone (CRH), the 
hypothalamic regulator of pituitary ACTH (Smith et al., 
1985). Additionally, ACTH production was inhibited by the 
synthetic glucocorticoid, dexamethasone, much like pituitary 
cells. Interestingly, this immune cell-derived ACTH was 
also shown to suppress antibody and lymphokine production 
(Johnson et al., 1982; Koff and Dunegan, 1985) thereby 
potentially acting in an autocrine/paracrine manner. Thus, 
these reports served as a benchmark demonstrating that 
products of the immune system could produce and respond to 
functional neuroendocrine hormones. 
Production of hormones by the immune system is not 
limited to the POMC-derived peptides but also includes 
thyrotropin (TSH) (Smith et al., 1983), chorionic 
gonadotropin (CG) (Harbor-McMennamin et al., 1986), growth 
hormone (GH) and prolactin-related peptides (Hiestand et 
al., 1986), somatostatin (Lygren et al., 1984; Goetzl et 
al., 1985), luteinizing hormone (LH) (Emanuele et al., 
1990), and vasoactive intestinal peptide (VIP) (Lygren et 
al., 1984), among others. Experimental evidence indicates 
that similar to the POMC peptides these immune-derived 
molecules may not only function to modulate neuroendocrine 
function but also may serve some local immunoregulatory 
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function. For example, the opioid peptides have been shown 
to stimulate NK cell activity (Koff and Dunegan, 1985) 
while GH enhances function of the cytotoxic T cell as well 
as T cell colony formation (Mercola et al., 1981; Snow, 
1985). In contrast, both somatostatin and VIP suppress 
immune function by inhibiting T cell proliferation (Payan et 
al• I 1986) 
In general, release of the neuroendocrine signalling 
molecules is positively regulated by an identified, specific 
stimulus. The hypothalamus, for example, releases CRH which 
directly stimulates the pituitary to release ACTH. In turn, 
this ACTH specifically stimulates adrenal cortical 
glucocorticoid secretion. Experimental evidence has 
accumulated which suggests that immune cell synthesis and 
release of hormone signalling molecules also occur in 
response to specific stimuli. Most of the aforementioned 
peptide hormones appear to be synthesized by leukocytes in 
response to both the classic neuroendocrine regulatory 
molecules and to specific immunologic stimuli. For 
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instance, TSH, the first de nova synthesized glycoprotein 
hormone found in the immune system, is synthesized and 
secreted by immune cells in response to the T cell mitogen 
staphylococcal enterotoxin A (SEA) (Smith et al., 1983) or 
thyrotropin releasing hormone (TRH) (Krueger et al., 1989). 
In contrast, a mixed lymphocyte reaction (MLR) is the only 
known stimulus for lymphocyte CG synthesis (Harbour et al., 
1986). 
Potentially, this information may be important when 
determining the physiologic significance of immune cell 
production of these peptides as well as provide insight into 
certain aspects of a pathophysiology related to an immune-
derived neuroendocrine hormone. Such information has been 
utilized, for example, in current models of pregnancy. 
Lymphocyte-derived CG has been speculated to be an important 
suppressive factor necessary for a successful implantation 
of the blastocyst and, ultimately, a successful pregnancy 
(Blalock, 1992). Collectively, these results suggest that 
cells of the immune system should now be considered a 
physiologically relevant source of neuroendocrine signalling 
molecules. 
II. Non-neurogenic Modulation of Chromaffin Cell 
Catecholamine Secretion 
Modification of neuroendocrine function by signalling 
molecules from other systems such as the immune system 
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extends to a variety of organs including the adrenal gland. 
As stated previously, the adrenal medulla secretes 
catecholamine during a typical stress response as a result 
of cholinergic stimulation of medullary chromaff in cell 
nicotinic and muscarinic receptors. Chromaf fin cell 
secretagogues, however, are now known to include several 
additional signalling molecules. These mediators include 
but are not limited to angiotensin II (Powis and O'Brien, 
1991), bradykinin (Owen et al., 1989), histamine (Bunn and 
Boyd, 1992), arachidonic acid (Negishi et al., 1990), as 
well as y-aminobutyric acid (GABA) (Gonzalez et al., 1992) 
Several studies have focused on characterizing the 
secretory mechanisms of each of these molecules. 
Catecholamine secretion in response to most of these 
secretagogues, like cholinergic catecholamine secretion, is 
a calcium dependent process (O'Sullivan et al., 1989; Cheek, 
1991). The only exception appears to be a non-calcium 
dependent catecholamine release observed in response to high 
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concentrations (0.1-1.0mM) of histamine (Goh and Kurosawa, 
1992). Interestingly, most of these mediators also utilize 
the phosphatidylinositol pathway to initiate chromaf fin cell 
exocytosis. Similar to muscarinic receptor activation, the 
binding of arachidonic acid (Negishi et al., 1990), 
histamine (Noble et al., 1986), bradykinin (Owen et al., 
1989), and angiotensin II (Sasakawa et al., 1989) to their 
respective chromaffin cell receptor stimulates 
phosphoinositide metabolism. Breakdown of membrane inositol 
phospholipids liberates the intracellular second messengers 
DAG and IP3 • Binding of the IP3 molecule to its 
intracellular receptor, a receptor-gated channel, leads to 
release of calcium from internal stores and a subsequent 
intracellular calcium rise in the chromaffin cell. This 
initial increase in intracellular calcium is then followed 
by an influx of calcium from external stores (Owen et al., 
1989; Negishi et al., 1990; Goh and Kurosawa, 1991; Powis 
and O'Brien, 1991). Apparently, influx of external calcium 
is essential for these secretagogues to stimulate 
catecholamine release since removal of extracellular calcium 
abolishes catecholamine secretion in all cases (Owen et al., 
1989; Negishi et al., 1990; Goh and Kurosawa, 1991; Powis 
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and O'Brien, 1991). 
Although histamine, bradykinin, angiotensin II, and 
arachadonic acid utilize the same second messenger system to 
increase intracellular calcium and stimulate catecholamine 
secretion, the efficacies of each of these chromaff in cell 
secretagogues differ considerably. Maximal histamine-
induced catecholamine secretion from chromaf fin cells is 
comparable to levels seen in cholinergic stimulation (Livett 
and Marley, 1986; Owen et al., 1989). Chromaf fin cell 
stimulation by angiotensin and bradykinin, however, leads to 
the release of only a modest amount of catecholamine (Bonn 
and Marley, 1989; Owen et al., 1989). There are potentially 
several reasons for the observed differences in 
catecholamine secretion in response to these secretagogues. 
For example, the efficacious chromaffin cell secretagogue 
histamine stimulates a prolonged, more global calcium influx 
(Staudermann et al., 1990; Staudermann and Pruss, 1990; 
Cheek et al., 1993) when compared to other less efficacious 
secretagogues such as angiotensin II and bradykinin. In 
addition, these secretagogues appear to elicit different 
patterns of second messenger formation/breakdown in these 
cells (Staudermann and Pruss, 1990; Plevin and Boarder, 
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1988) . Although knowledge of these systems is limited, the 
spatial and temporal variations in intracellular calcium as 
well as different patterns of second messengers may be 
reasons for the differences in catecholamine secreted in 
response to these molecules. 
RATIONALE 
Recent investigations from this laboratory provide 
evidence for yet another non-neural chromaff in cell 
secretagogue of immunologic origin. In vitro experiments 
have demonstrated that factor(s), like ACTH and the 
endorphins (Smith and Blalock, 1981; Smith et al., 1982), 
released by immune cells may potentially act in vivo to 
modulate adrenal medullary catecholamine release (Wang, 
1992; Jones et al., 1993) . Preliminary data indicate that 
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these factor(s) are small molecular weight peptide(s) 
(<3,000) and are present and active in a variety of species 
(bovine, porcine, human) . Similar to histamine, these 
unidentified factor(s) stimulate adrenal medullary 
chromaf fin cell secretion to levels comparable to maximal 
cholinergic release (Jones et al., 1993). The following 
dissertation research was performed to further identify and 
characterize these immune-derived factor(s). Identification 
and characterization of immune-derived signalling molecules 
which may modulate neuroendocrine function (i.e. chromaffin 
cell epinephrine secretion) will provide insight to the 
potential homeostatic importance of intersystems 
communication. Results of these studies will provide a 
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foundation for future studies of immunomodulation of stress 
hormone release. As mechanisms of stress-associated 
immunologic changes and immune modulation of the stress 
response are understood, manipulation of these systems and 
improved patient outcome to stress and infectious challenge 
becomes possible. 
CHAPTER III 
MATERIALS AND DETAILED METHODS 
A. Cell Culture 
I. Primary Cultures of Chromaffin Cells 
a. Isolation and Culture: Chromaffin cells were 
isolated from adult bovine adrenal glands according to the 
overall procedure described by Dahmer et al. (1990). In 
brief, adrenal glands were perfused with collagenase, 
incubated at 37°C and medullary tissue removed for further 
digestion. Digested cells were washed, counted, viability 
determined with trypan blue and purity assessed with neutral 
red. Cells were plated on collagen-coated 24-well plates at 
a density of 3Xl0 5 cells per cm2 and media was changed after 
the first day and then as needed to maintain a normal pH. 
b. Chromaffin Cell Culture Media: Primary cultures of 
chromaffin cells were maintained 4-7 days subsequent to 
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their isolation in media comprised of equal parts of F-12 
Nutrient Mixture (Gibco BRL, Gaithersburg, MD) and 
Dulbecco's Modified Eagle's Medium (D-MEM, Gibco BRL, 
Gaithersburg, MD). Five hundred milliliters of this media 
contains 5 ml lM HEPES, 55.6 mg penicillin, 220 µl 
gentamicin (50 mg/ml), 62.3 µl cytosine ~-arabinofuranoside 
(Ara-C, 28 mg/ml), 53.4 µl 5-fluoro-2'-deoxyuridine (5-FDU, 
24 mg/ml), and 2.76 ml Nystatin suspension (10,000 
units/ml) . Media is supplemented with fetal bovine serum 
(FBS, 10% v/v) and 5.6 ml filter-sterilized L-glutamine (200 
mM) is added every thirty days. 
c. In vitro Model of Catecholamine Secretion: Basic 
secretion experimental protocols are those described by 
Dahmer et al. (1990). In brief, growth media was removed 
and replaced with conditioned media (0.5ml, 90 min. 
incubation), serum-free RPMI-1640 (0.5ml, 90 min. 
incubation), Earle's Balanced Salts Solution (EBSS, 0.5ml, 
90 min.), or secretagogue in EBSS (0.5ml, 10 min. 
incubation) . After incubation, media was removed and saved. 
Catecholamine content in these samples represent that 
stimulated by conditioned media (CM), spontaneous/basal 
secretion (RPMI/EBSS) , or that stimulated by a known 
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secretagogue. Cells were lysed by lM perchloric acid 
(l.Oml) and saved to determine the remaining catecholamine 
content of the cells. The fraction of catecholamine 
(epinephrine) secreted into the media as a percent of total 
content was calculated by dividing the amount secreted by 
the total well content. Secretion experiments were 
routinely done in triplicate using three separate wells on 
any one plate which were derived from the same adrenal 
gland. Replicates of separate triplicate determinations 
were made on cells from different chromaff in cell 
preparations. Cell epinephrine content (ng/10 6 cells) 
ranged from 13.5±0.4 µg to 19.8±0.6 µgin all preparations. 
Epinephrine was quantified by HPLC using electrochemical 
detection. Mobile phase was O.lM monochloroacetic acid with 
O.SmM EDTA and l.OmM sodium octyl sulfate adjusted to pH 
3.0. Acetonitrile was added at 15ml/L. A BAS Liquid 
Chromatographic System including an LC 4C electrochemical 
detector and glassy carbon electrode was used for all 
analyses. 
d. Data Analysis: All data are presented as epinephrine 
secretion as a percent of total cell content. Percent 
secretion of each experimental and control group(s) are 
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compared with every other group using an analysis of 
variance (ANOVA). A Tukey's follow-up test is utilized when 
statistically significant differences are found between 
groups. A p<.05 is considered statistically significant. 
II. Primary Cultures of Mononuclear Cells from Spleen 
a. Isolation and Culture: Whole bovine spleen was 
obtained from a local slaughter house. Inner spleen tissue, 
which includes both red and white pulp, was dissected out, 
cut into small pieces and forced through wire mesh in Hank's 
Balanced Salts Solution (HBSS) at room temperature. Crude 
cell suspensions were layered on density gradient media 
(Fico/Lite-LymphoH, Atlanta Biologicals), centrifuged and 
then separated cells were removed and washed. Isolated 
cells were transferred to flasks with RPMI media containing 
only essential amino acids and antibiotics at a density of 
2Xl0 6 cells/ml. The growth media was isolated from the 
cells and either used promptly or frozen (-20°C) after at 
least 24 hours of culture. This media taken from 
mononuclear cell cultures containing all factors released by 
the mononuclear cell populations is referred to as 
conditioned media (CM) . Secretion experiments utilized CM 
filtered through Centricon filters (3,000 MW cutoff) to 
remove all factors greater than 3,000 MW. 
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b. Mononuclear Cell Culture Media: Isolated 
bovine splenocytes were maintained in serum-free RPMI-1640 
(Gibco BRL, Gathersburg, MD). Five hundred milliliters of 
this medium contained 1 g NaHC03 , 0.5 ml gentamicin 
(50mg/ml), 5 ml Dulbecco's Modified Eagle Medium (D-MEM), 5 
ml penicillin-streptomycin (5,000 units/ml penicillin; 5,000 
µg/ml streptomycin), and 25 µl 2-Mercaptoethanol (2-ME, lM). 
L-glutamine (5.6 ml, 200mM stock) was added to media every 
thirty days. 
c. Epinephrine Co-Culture: Isolated bovine mononuclear 
cells were counted and suspended in RPMI-1640 at 2X10 6 
cells/ml. Aliquots of cell suspension were then placed into 
25 cm2 tissue culture flasks with or without various 
concentrations of epinephrine (lnM - lµM, Sigma Chemical Co, 
St. Louis, MO) and cells were allowed to incubate at 37°C 
for 24 hours. At that time, cell supernatant was harvested 
and then used in secretion experiments or frozen (-20°C) for 
future use. Epinephrine (1 µM), in the presence of the ~­
adrenergic receptor antagonist, propranolol (100 µM), was 
also incubated overnight with mononuclear cell cultures. 
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Since epinephrine may remain unoxidized in the supernatant 
of these cultures after the twenty-four hour culture period, 
experiments were performed concurrently to determine the 
amount of residual catecholamine. The various 
concentrations of epinephrine (1 nM - 1 µM, in RPMI-1640) 
were incubated at 37°C for 24 hours then analyzed using 
HPLC. Oxidation of epinephrine in cell cultures was 
minimized by the presence of either 0.2 mg NaS03 /ml RPMI or 
0.1% ascorbic acid. 
III. Hybridoma Cell Lines 
a. IL-ASl/anti CD-8: The immortal cell line IL-ASl, a 
murine hybridoma cell line producing monoclonal antibody 
(IgGl) to the bovine orthologue of human CDB, was obtained 
from American Type Culture Collection (ATCC, Rockville, MD). 
Cells were cultured at the concentration of 10 6 cells/ml in 
a media comprised of RPMI-1640 supplemented with 10% (v:v) 
fetal bovine serum and 20 µM 2-Mercaptoethanol. Cultures 
were maintained by adding fresh media every 2-3 days as 
needed. 
b. IL-All/anti CD-4: The immortal cell line IL-All, a 
murine hybridoma cell line producing monoclonal antibody 
(IgG2a) to the bovine orthologue of human CD4, was obtained 
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from American Type Culture Collection (ATCC, Rockville, MD) . 
Cells were cultured at the concentration of 10 6 cells/ml in 
RPMI-1640 supplemented with 10% fetal bovine serum and SOµM 
2-Mercaptoethanol. Cultures were maintained by the addition 
of fresh media every 2-3 days as necessary. 
B. Mononuclear Cell Separation/Purification 
I. Separation of Monocyte/Macrophage Populations 
The monocyte/macrophage populations were isolated from 
other splenocytes based on 1 hour adherence to plastic in 
culture flasks at 37°C (Clarke et al., 1993). Purity of the 
monocyte/macrophage cultures was assessed using two 
different staining methods. Wright-Giemsa staining was used 
to ensure no other adherent cell populations (i.e. dendritic 
cells, fibroblasts) were present in the culture. Non-
specific esterase activity, unique to monocyte/macrophage 
mononuclear cells, was used to determine contamination of T 
and B cell populations in adherent cell cultures. 
II. T cell/B cell Isolation and Separation Using 
Monoclonal Antibodies 
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In 1975, Kohler and Milstein described a technique for 
immortalization of B cells that produce a specific antibody. 
The method involves cell fusion between a normal antibody-
producing B cell and a myeloma line, and selection of fused 
cells that secrete antibody of the desired specificity 
derived from the normal B cell. Such fusion-derived 
immortalized antibody-producing cells lines are referred to 
as hybridomas. Hybridomas producing monoclonal antibodies 
specific to the bovine orthologues of the human CD4 and CDS 
molecules were obtained from American Type Culture 
Collection (Rockville, MD) and these cells were cultured 
according to given protocols. 
a. Isolation of Antibody from Hybridoma Cultures: 
Hybridoma cultures were allowed to grow until culture media 
was turbid. The hybridoma cell culture flask was then 
agitated, lysing cells and maximizing antibody concentration 
in the suspension. The cell suspension was then centrifuged 
at 2000g at 4°C. The supernatant was poured over a Proteins 
A/G column, bacterial products that bind the Fe portion of 
the antibody, and purified antibody was eluted from the 
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column using O.lM glacial acetic acid (pH=2.0). Absorbance 
at 206 nm of column effluent was used to indicate antibody 
elution. 
b. Antibody Biotinylation and Coupling to Magnetic 
Microbead: Antibody was conjugated with magnetic microbeads 
using the avidin-biotin system. Briefly, antibody was 
dialyzed against O.lM NaHC03 (pH 8.4) overnight and 
concentration after dialysis determined via spectrophometric 
analysis using the Bradford assay. Antibody was then 
concentrated or diluted to obtain a final concentration of 1 
mg/ml. Immediately before use, 1.63 mg of NHS-LC-biotin 
(Pierce, Rockford, IL) was dissolved in 1 ml of dimethyl 
sulfoxide (DMSO) in a glass tube. This mixture was 
triturated and 50 µl was added to 1 ml antibody solution. 
This procedure results in a biotin substitution ratio of 
approximately 8:1. The reaction was allowed to proceed at 
room temperature for one hour. The reaction mixture was 
then dialyzed against 0.1 M NaHC03 for 48 hours. Sodium 
azide was not used since antibody labeled cells were 
maintained in culture for an extended period (24-48h) 
c. Magnetic-based Cell Separation: Biotinylated 
antibody, anti CD4 or anti CDS, was added to the lymphocyte 
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cell suspension for 10 min to allow for adequate labeling 
with antibody and unbound/excess antibody then removed by 
three cold PBS washes (pH 7.4). Biotinylated antibody, 
bound to its respective cell surface marker, was coupled to 
a streptavidin linked magnetic microbead during a 10 min. 
incubation on ice, a reaction which occurs due to the high 
affinity of streptavidin for biotin (Ka=10- 19M) . Cells were 
again washed in PBS and labeled cells passed over a magnetic 
column. In theory, all cells labeled with magnetically-
conjugated antibody will be retained on the column while any 
unlabeled cells should pass through. Labeled cells, still 
bound to magnetic beads, are then be released from the 
column by removing the column from the magnetic field and 
washing several times in cold PBS. These cells, still 
labeled with antibody, may then be cultured according to 
standard conditions. This protocol was followed twice for 
each lymphocyte preparation, one passage to separate CD4 
positive lymphocytes and a second to isolate CDS positive 
lymphocytes. B cells were considered to be those 
populations which were not labeled by magnetically linked 
antibody and thus wash through the column. Purity of these 
cultures, as assessed using Fluorescence Activated Cell 
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Sorter (FACS), was between 80% and 90%. 
C. Peptide Purification and Isolation 
I. G-25 Sephadex Column Gel Filtration 
G-25 Sephadex beads (10 g) were combined with deionized 
water at a ratio of 1 g per 2-3 ml water yielding a final 
volume of approximately 30 ml and equilibrated for 8-10 
hours. This volume was placed in a 2 cm column which was 
attached to a continuous perfusion pump with a loop 
containing an injection valve and equilibrated with 
phosphate buffered saline (PBS, pH 7.2). Conditioned media 
(2 ml) was introduced using the loop. The molecular weight 
standard Blue Dextran (MW 2X10 6 ) was totally excluded from 
the beads and provided a measure of the void volume. 
Potassium chromate (MW 194) totally penetrates the Sephadex 
beads and was used to determine the total volume. Fraction 
collection (2 ml each) began when the void volume was eluted 
and continued until the total volume was removed from the 
beads. Absorbance at 206 nm was measured as the fractions 
were eluted from the column and was used to indicate the 
presence of peptide. 
II. Polyacrylamide Gel Electrophoresis (PAGE) 
Basic methods were similar to those described by 
Schagger and van Jagow (1987). In brief, a 20% acrylamide 
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separating gel was prepared containing 3.0 M Tris (pH 8.45) 
and glycerol. This was overlaid with a 10% spacer gel, 
followed by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding 
a gel with approximate dimensions of 0.75mm X 6.5cm X 8.0cm. 
A discontinuous buff er system was utilized which included a 
Tris-base (pH 8.9) anionic buffer and a Tricine/Tris 
cationic buffer. Approximately 20 µg of sample was loaded 
into each lane and a constant voltage was applied to the gel 
(20V for 1 hour followed by lOOV for 1-1.5 hours). The gel 
was removed from the apparatus once the dye front reached 
the anionic buffer-gel interface. The gel was then stained 
with Coomassie Blue or silver. 
D. Intracellular Calcium Measurements in Chromaffin Cells 
I. Solutions 
a. Fura-2 AM: Permeability of the fura-2 molecule is 
achieved by addition of the acetoxymethyl (AM) ester group 
to the molecule, which masks the negatively charged carboxyl 
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groups rendering the molecule uncharged, hydrophobic, and 
able to cross the cell membrane. Once the fura-2 is 
internalized, nonspecific esterases cleave the AM group thus 
liberating the polycarboxylate form of the fura-2 molecule 
which, due to its charge, becomes trapped in the cell. 
Since AM esters are relatively insoluble in aqueous 
solutions, the mild nonionic surfactant Pluronic F127 is 
used as a dispersing agent. Additionally, serum proteins 
such as bovine serum albumin (BSA) , which have been shown to 
improve loading efficiency possibly by acting as hydrophobic 
carriers of the AM ester, may also be used to maximize 
loading. The AM ester form of fura-2 was used in all 
analyses of intracellular calcium. A solution of BSA (1 
mg/ml) was made and then triturated. In a plastic test 
tube, equal volumes of a 20% (weight:volume) solution of 
Pluronic F127 in DMSO and fura-2 AM (lmM in DMSO) were 
combined and vigorously mixed using the vortex. 
Approximately 2ml of BSA solution was added to the tube and 
contents were mixed once again. The contents of the test 
tube were then combined with additional BSA solution such 
that the final solution contained lµM fura-2 AM, 0.1% BSA, 
and 0.02% Pluronic F127. The fura-2 concentration was kept 
as low as possible to reduce overloading artifacts which 
include incomplete hydrolysis, compartmentalization, and 
toxicity from hydrolysis by-products (i.e., formaldehyde). 
b. Modified Kreb 1 s Buffer: A Modified Kreb's Buffer 
Solution was used in all incubations and washes. This 
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solution contained NaCl 7.8 g/L (135 mM), KCl 0.44 g/L (5.9 
mM), CaCl 2 0.22 g/L (1.5 mM), MgC1 2 0.24 g/L (1.2 mM), HEPES 
2.76 g/L (11.6 mM), and D-glucose 2.07 g/L (11.5 mM). This 
solution was used at a pH of 7.3. 
c. Calcium Standard Buffer: A Calcium Standard Buffer 
was used for both in vitro and in situ calibrations. This 
buffer contained 3.728 g KCl/450 ml (110 mM), 1.046 g 
MOPS/450 ml (11.1 mM), and 0.1015 g MgC12 /450 ml (1.1 mM) 
and was titrated to a pH of 7.2 with KOH. 
d. Buffer 11 A11 : Used in both in vitro and in situ 
calibrations, Buffer "A" is a lOmM K2 EGTA solution. This 
solution was prepared by adding 3.804 g of the calcium 
chelator EGTA (lOOmM) to 90 ml of Calcium Standard Buffer. 
Once the EGTA was solubilized, the solution was titrated to 
a pH of 7.2 with KOH and then to a final volume of 100 ml. 
e. Buffer 11 B11 : Buffer "B", a lOmM CaEGTA solution, was 
used in both in vitro and in situ calibrations. EGTA (3.804 
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g) and CaC03 (1.001 g) were added to 90 ml of Calcium 
Standard Buffer. This solution was then titrated to a pH of 
7.2 with KOH and a final volume of 100 ml. 
II. Calibrations 
a. In Vitro: Measurement of fluorescence intensities 
at varying calcium concentrations under cell free conditions 
was achieved using fura-2 (free acid, 1 µM) addition to 
solutions of known calcium content and measurement of each 
respective fluorescence intensity. Free calcium 
concentrations were determined using the Maxchelator 
program. Fluorescence intensities were measured at 
excitation wavelengths of 340 and 380 nm and an emission 
wavelength of 510 nm. The solutions were as follows: 
Free Ca2 + {nM) Buffer"A" {ml/ml) Buffer"B" {ml/ml) FreeMg2 + {mM) 
0 1.000 0 0.64 
10 0.937 0.063 0.65 
50 0.748 0.252 0.70 
100 0.598 0.402 0.75 
200 0.427 0.573 0.81 
500 0.230 0.770 0.81 
1000 (lµM) 0.130 0.870 0.93 
2000 (2µM) 0.070 0.930 0.97 
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Intensity readings from the dual excitation wavelengths 
were obtained and divided (340/380) yielding ratio values. 
These ratios for each calculated calcium concentration were 
fit to a curve. This curve was then compared to in situ 
calibration results as well as experimental data. 
b. In Situ: To account for cell-specific modifications 
in recorded fluorescence (i.e. intracellular buffering 
capacity) as well as any variation in cell preparation, in 
situ calibrations were performed at the end of each 
experiment. Briefly, cells were perfused with Buffer "A" 
containing 10 µM ionomycin, an ionophore, and 4 mg/L 
nigericin. Nigericin, a hydrogen-potassium exchanger, was 
used to compensate for any changes in intracellular pH due 
to the action of the calcium-hydrogen exchanging ionomycin. 
After 20 minutes of perfusion a fluorescence measurement was 
taken and recorded as Rmin. At this point, the perfusing 
solution was switched to Buffer "B" containing lOµM 
ionomycin, 4 mg/L nigericin, and lOmM calcium chloride. The 
cells were perfused with this solution for 5-10 minutes at 
which time fluorescence readings were taken. The maximal 
fluorescence ratio at the end of the perfusion was recorded 
as Rmax. Calibration software, incorporated into the Perkin 
Elmer system utilized for these measurements, allowed for 
the measurement and automatic subtraction of all 
autofluorescence at both wavelengths. 
III. Procedure 
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a. Preparation of Chromaffin Cells: Chromaffin cells 
were isolated as described previously (Cell Culture) . 
Purified cells used in fura-2 analyses were plated on 
collagen-coated coverslips (9X22 mm) at the same density as 
those cells used in secretion protocols (3Xl0 5 cells per 
cm2 ) • Cells were maintained on coverslips in 60 mm tissue 
culture dishes. Media was changed after the first day in 
these cultures and then as needed to maintain normal pH. 
b. Loading Fura-2 AM: Fura-2 AM solution (lµM) was 
added to 60 mm tissue culture dishes containing chromaff in 
cell coverslips and cells were incubated at room temperature 
for one hour. Dishes were covered with aluminum foil during 
the incubation period to inhibit exposure to light. Cells 
were washed twice in Modified Kreb's Buffer Solution prior 
to experimental use. 
c. Measurement of Intracellular Calcium Concentration: 
Chromaff in cell coverslips were placed in a perfusion 
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apparatus which was subsequently placed in a disposable 
cuvette. Fluorescence intensity was measured using the 
Perkin-Elmer LS SOB Luminescence Spectrometer and 
accompanying software. Fluorescence scanning time ranged 
from 5 to 90 minutes. A baseline calcium measurement was 
obtained by fluorescence measurement for 40 to 60 seconds 
prior to the addition of secretagogue or drug. 
Secretagogues (2 ml) were added using a 3 ml syringe and 25 
gauge needle while drugs (10µ1) were injected using a 
Hamilton syringe (Hamilton Co., Reno, NE). The system was 
run via gravity feed (approximately 1 ml/min) and all 
effluent was collected in a vacuum flask. All experiments 
were performed at room temperature. Fluorescence 
intensities were obtained using excitation wavelengths of 
340 and 380nm and measuring emission at 510 nm. Reported 
ratios represent fluorescence intensity at 340 nm excitation 
divided by that obtained with 380 nm excitation. 
Intracellular calcium levels were determined by the 
equation: 
Rmax - R Sb2 
Where Kd = 135nm (room temperature), Rmin and Rmax are 
fluorescence ratios at zero and calcium levels which 
saturate the calcium binding capacity of fura-2 AM 
respectively, and Sf2/Sb2 is the ratio of excitation 
efficiencies for free and bound fractions at 380nm 
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(Grynkiewicz, 1985). Ratioing not only results in 
measurement of intracellular calcium concentrations that are 
essentially independent of intracellular dye concentrations 
but also off sets the complications of leakage and 
photobleaching. 
d. Data Analysis: Fluorescence intensity data from each 
experiment were converted to calcium concentrations 
utilizing a self-designed look-up table. This look-up table 
was constructed using the Grynkiewicz and other mathematical 
equations and data obtained from in vitro and in situ 
callibrations. The final data are presented as the change 
in intracellular calcium concentration (ordinate) of the 
chromaff in cell population over time (abscissa) in response 
to CM or secretagogue. 
60 
E. Antibody Production 
I. Carrier Protein 
a. Selection of Carrier Protein: The production of 
antibody to concentrated peptide required the immunization 
of rabbits with peptide. For these studies, the 
concentrated peptide was conjugated with a carrier protein 
to increase antigenicity. The carrier protein that was 
employed was Keyhole Limpet Hernocyanin, a large irnrnunogenic 
protein obtained from Sigma Chern. Co. (St. Louis, MO). 
b. Coupling the Enriched Peptide Fraction to Carrier 
Protein: Glutaraldehyde was utilized which coupled peptide 
to carrier protein primarily through the N terminal alpha 
amino acid of the peptide. This procedure was described 
previously and requires the mixing of the carrier protein 
with the concentrated peptide followed by cross-linking with 
0.3% glutaraldehyde (van Regenrnortel et al., 1988). The 
peptide coupled carrier protein was then dialyzed against 
borate buffer (pH 8.5) for 48h. 
II. Polyvalent Antibody Production 
New Zealand White rabbits were bled prior to 
immunization to obtain a baseline and ensure no peptide-
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specific antibody was present in the blood prior to 
immunization. 1 mg of the peptide/protein carrier complex 
was dissolved in 0.05 M phosphate buffered saline (PBS) and 
mixed with an equal volume of Freund's Adjuvant and injected 
into each rabbit subcutaneously near the axillary lymph 
nodes and intramuscularly in the hind leg. At two week 
intervals the animals were reinjected with the 
peptide/protein carrier complex in adjuvant. Following the 
second such injection, the animals were bled through the 
medial ear artery to obtain 5 ml of blood. The serum was 
separated and assessed for reactive antibody as described 
below (ELISA) . Antisera was also tested in a bioassay to 
ensure antibody to a bioactive peptide is present. 
III. Development of an ELISA 
The enzyme linked immunoabsorbent assay (ELISA) is an 
important immunologic technique by which one can quantify 
antigen (e.g. peptide) concentration by using an indicator 
molecule (antibody) coupled covalently to an enzyme. 
Antigen/peptide is quantified by determining the initial 
rate at which enzyme converts a clear substrate in the 
solution to a colored product. Initially, an ELISA was 
developed to determine peptide-antibody presence in both 
rabbit and mouse polyvalent antisera. Methods are well 
characterized (van Regenmortel et al, 1988) and are 
described below. 
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Briefly, a fixed quantity of concentrated peptide was 
attached to 96 well assay plates and incubated overnight at 
4°C in phosphate buffered saline (PBS) at pH 7.2. Once the 
concentrated peptide was attached to the wells, the plastic 
plates were washed with PBS containing 0.05% Tween-20. The 
remaining active sites were blocked with 0.05% gelatin 
(Sigma Chem. Co., St. Louis, MO) for 2 hours at room 
temperature and wells washed again with PBS containing 0.05% 
Tween-20. Serial dilutions of antibody were prepared and 
incubated with a fixed amount of polyvalent antisera in the 
coated plastic wells overnight at 4° C. Wells were then 
washed at least three times with PBS containing 0.05% Tween-
20. To measure the amount of specifically bound polyvalent 
antisera, each well was incubated with peroxidase coupled 
secondary antibody for 2 hr at 37°C (in this case a goat 
anti-rabbit secondary antibody, Accurate Chem. Corp., 
Westbury, NY). The plastic wells were then washed at least 
three times with PBS containing 0.05% Tween-20. 3,3'-
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Diaminobenzidine tetrahydrochloride (DAB, 0.5 mg/ml), the 
enzyme substrate, was combined with PBS (pH=7.2) containing 
0.3% H20 2 then lOOµL of this solution was placed in each 
well and allowed to incubate for 1-3 hours at 37° C. 
Positive results, i.e. antibody binding specifically to 
peptide sequence, were indicated by a color change in the 
corresponding well. The intensity of the color would then 
be indicative of the amount of peptide bound in each well. 
Since the conversion of the chromagen, DAB, yields the color 
brown in a positive test, all plates were scanned at 492 nm 
absorbance to determine relevant peptide concentrations in 
each well. 
CHAPTER IV 
SIGNAL TRANSDUCTION AND THE IMMUNE-DERIVED PEPTIDE: 
THE ROLE OF CALCIUM IN SECRETION 
A. Introduction 
The importance of stress in the etiology and prevention 
of disease is becoming increasingly apparent as the 
mechanics of stress-induced dyshomeostasis are understood. 
Extensive documentation demonstrates that humans can respond 
to both cognitive and non-cognitive stimuli through a stress 
response that results in the release of the stress hormone 
epinephrine into the circulation. This increased plasma 
epinephrine has a wide array of physiologic effects ranging 
from substrate mobilization supporting the hypermetabolism 
of fever to increased cardiovascular function. 
Interestingly, recent documentation indicates that 
epinephrine also may modify various immune cell functions 
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thus potentially altering the immune response in times of 
stress (Sanders and Munson, 1985; Feldman et al., 1987; 
Plaut, 1987; Heilig et al., 1993). Typically, adrenal 
medullary release of epinephrine is attributed to neural 
stimulation of adrenal medullary chromaffin cells. Recent 
studies from this and other laboratories, however, indicate 
that medullary epinephrine release may also be mediated 
through a non-neural mechanism (Seidler and Mills, 1989; 
Zhou and Jones, 1993). Further experimental evidence 
indicates that one source of this regulation potentially 
lies in the immune system (Jones et al., 1993). Primary 
cultures of mononuclear cells from bovine, porcine and human 
sources have been shown to release a small (MW< 3,000) 
peptide which stimulates medullary epinephrine secretion to 
levels comparable to maximal cholinergic stimulation. 
Although knowledge of the exact mechanism of chromaffin 
cell exocytosis is poorly understood, one common feature of 
all models is that catecholamine secretion is dependent on 
an increase in intracellular calcium. Initial reports 
documented that a rise in intracellular calcium is a 
sufficient stimulus to trigger chromaff in cell exocytosis 
(Dunn and Holz, 1983). Later studies employed the use of 
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calcium sensitive fluorescent dyes (e.g. fura-2) to 
temporally and spatially resolve the relationship between 
increased intracellular calcium and exocytosis (Kirn and 
Westhead, 1989; O'Sullivan and Burgoyne, 1989; Cheek et al., 
1989; Stauderrnan et al., 1990). Ultimately, investigations 
revealed that chrornaf fin cell secretion in response to known 
secretagogues, both cholinergic and non-cholinergic 
mediators, is a calcium dependent process (O'Sullivan et 
al., 1989; Cheek, 1991). The goal of the current study was 
to assess the basic signal transduction mechanism of this 
immune-derived peptide in chrornaffin cell catecholamine 
secretion and to determine if the mechanism was similar to 
other known secretagogues. Central to this goal was 
elucidating the role of calcium in peptide-induced 
excitation-secretion coupling. 
Multiple studies have documented the fact that adrenal 
rnedullary chrornaff in cells secrete catecholamine in response 
to a rise in cytosolic calcium concentration ( [Ca2 +] J (Cheek 
and Thastrup, 1989; O'Sullivan and Burgoyne, 1989; 
Stauderrnan et al, 1990). This rise in intracellular calcium 
can result from calcium influx, release of calcium from 
internal stores, or a combination of both. Bovine chrornaffin 
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cells, the model system used in these experiments, appear to 
require the influx of extracellular calcium to induce 
catecholamine secretion since muscarinic agonists, coupled 
solely to internal calcium release, are ineffective 
secretagogues. Utilizing purified fractions of immune-
derived peptide, experiments were conducted using non-
specific as well as specific calcium channel blockers to 
determine if peptide-induced secretion was, indeed, 
dependent on calcium and, if so, to determine the importance 
of extracellular and/or intracellular stores. Further 
experiments were performed using the fluorescent calcium 
indicator, fura-2, to temporally resolve internal 
oscillations in calcium in response to immune-derived 
peptide stimulation. 
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B. Materials and Methods 
Primary Cultures of Chromaffin Cells 
a. Isolation and Culture: Adult bovine adrenal glands 
were used for chromaf fin cell isolation according to the 
overall procedure described by Dahmer et al., (1990). In 
brief, adrenal glands were perfused with collagenase, 
incubated at 37°C and medullary tissue removed for further 
digestion. Digested cells were washed, counted, viability 
determined with trypan blue and purity assessed with neutral 
red. Cells were plated on collagen-coated 24-well plates at 
a density of 3Xl0 5 cells per cm2 and media was changed after 
the first day and then as needed to maintain a normal pH. 
b. In vitro Model of Catecholamine Secretion: Basic 
secretion experimental protocols are those described by 
Dahmer et al., (1990). In brief, growth media was removed 
and replaced with conditioned media (90 min. incubation), 
serum-free RPMI-1640 (90 min. incubation), Earle's Balanced 
Salts Solution (EBSS, 90 min.), or secretagogue in EBSS (10 
min. incubation). After incubation, media was removed and 
saved. Catecholamine content in these samples represent 
that stimulated by conditioned media (CM) , basal secretion 
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experiments), or that stimulated by a known secretagogue. 
Cells were lysed by lM perchloric acid and acid saved to 
determine the remaining catecholamine content of the cells. 
The fraction of epinephrine secreted into the media as a 
percent of total content was calculated by dividing the 
amount secreted by the total well content. Secretion 
experiments were routinely done in triplicate using three 
separate wells on any one plate which were derived from the 
same adrenal gland. Replicates of separate triplicate 
determinations were made on cells from different chromaff in 
cell preparations. Catecholamines were quantified by HPLC 
using electrochemical detection. Mobile phase was O.lM 
monochloroacetic acid with O.SmM EDTA and 1.0mM sodium octyl 
sulfate adjusted to pH 3.0. Acetonitrile was added at 
15ml/L. A BAS Liquid Chromatographic System including an LC 
4C electrochemical detector and glassy carbon electrode was 
used for all analyses. 
Primary Cultures of Mononuclear Cells from Spleen 
Isolation and Culture: Whole bovine spleen was 
obtained from a local slaughter house. Inner spleen tissue, 
which includes both red and white pulp, was dissected out, 
cut into small pieces and forced through wire mesh in Hank's 
Balanced Salts Solution (HBSS) at room temperature. Crude 
cell suspensions were layered on density gradient media 
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and 
then separated cells were removed and washed. Isolated 
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cells were transferred to flasks with RPMI media containing 
only essential amino acids and antibiotics at a density of 
2Xl0 6 cells/ml. The growth media was isolated from the 
cells and either used promptly or frozen (-20°C) after at 
least 24 hours of culture. 
Data Analysis 
All data are presented as epinephrine secretion as a 
percent of total cell content. Percent secretion of each 
experimental and control group(s) are compared with every 
other group using an ANOVA. A Tukey's follow-up test is 
utilized when statistically significant differences are 
found between groups. A p<0.05 is considered statistically 
significant. 
Intracellular Calcium Measurements in Chromaffin Cells 
The calcium sensitive fluorescent dye, fura-2, was 
utilized to temporally resolve changes in intracellular 
calcium concentrations in response to CM-peptide. Peptide-
stimulated alterations in intracell calcium were measured in 
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the presence and absence of non-specific calcium channel 
blockers to determine relative amounts of calcium influx as 
well as release from internal stores. 
a. Preparation of Chromaffin Cells: Chromaffin cells 
were isolated as described previously (Cell Culture) . 
Purified cells used in fura-2 analyses were plated on 
collagen-coated coverslips (9X22 mm) at the same density as 
those cells used in secretion protocols (3X10 5 cells per 
cm2 ) • Cells were maintained on coverslips in 60 mm tissue 
culture dishes. Media was changed after the first day in 
these cultures and then as needed to maintain normal pH. 
b. Loading Fura-2 AM: Fura-2 AM solution (lµM) was 
added to 60 mm tissue culture dishes containing chromaffin 
cell coverslips and cells were incubated at room temperature 
for one hour. Dishes were covered with aluminum foil during 
the incubation period to inhibit exposure to light. Cells 
were washed twice in Modified Kreb's Buffer Solution prior 
to experimental use. 
c. Measurement of Intracellular Calcium Concentration: 
Chromaff in cell coverslips were placed in a perfusion 
apparatus which was subsequently placed in a disposable 
cuvette. Fluorescence intensity was measured using the 
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Perkin-Elmer LS SOB Luminescence Spectrometer and 
accompanying software. Fluorescence scanning time ranged 
from 5 to 90 minutes. A baseline calcium measurement was 
obtained by fluorescence measurement for 40 to 60 seconds 
prior to the addition of secretagogue or drug. 
Secretagogues (2 ml) were added to the perfusion apparatus 
using a 3 ml syringe and 25 gauge needle while drugs (10µ1) 
were injected using a Hamilton syringe (Hamilton Co., Reno, 
NE) . All experiments were performed at room temperature 
(23°C) Fluorescence intensities were obtained using 
excitation wavelengths of 340 and 380nm and measuring 
emission at 510 nm. Reported ratios represent fluorescence 
intensity at 340 nm excitation/ that obtained with 380 nm 
excitation. 
Intracellular calcium levels were determined by the 
equation: 
Rmax - R Sb2 
Where Kd = 135nm (room temperature), Rmin and Rmax are 
fluorescence ratios at zero and calcium levels which 
saturate the calcium binding capacity of fura-2 AM 
respectively, and Sf2/Sb2 is the ratio of excitation 
efficiencies for free and bound fractions at 380nm 
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(Grynkiewicz, 1985). Ratioing not only results in 
measurement of intracellular calcium concentrations that are 
essentially independent of intracellular dye concentrations 
but also off sets the complications of leakage and 
photobleaching. 
Data Analysis 
Fluorescence data from each experiment were converted 
to the appropriate calcium concentration utilizing a self-
designed look-up table. This look-up table was constructed 
using the Grynkiewicz and other mathematical equations and 
data obtained from in vitro and in situ calibrations. The 
final data are presented as the change in intracellular 
calcium concentration (ordinate) of the chromaffin cell 
population over time (abscissa) in response to CM or 
secretagogue. 
C. Results 
Extracellular Calcium is Essential for Conditioned Media-
Induced Secretion. 
Extracellular calcium influx in response to peptide 
stimulation was inhibited by the non-specific calcium 
channel blocker cobalt (CoC121 2mM) . As can be seen in 
figure 1, the channel blocker completely inhibited 
catecholamine secretion in response to conditioned media 
indicating that peptide-induced secretion requires the 
influx of extracellular calcium 
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Blockers of voltage-gated calcium channels do not completely 
inhibit secretion in response to peptide. 
Since bovine chromaffin cells contain the L, P, Q, and 
N-type voltage-gated calcium channels (Lopez et al., 1989; 
Lopez et al., 1994), specific blockers of these channels 
were used to asses the role of each channel type in peptide-
induced calcium influx. Both the L- and P-type channel 
blockers, verapamil (lµM) and w-Agatoxin VIA (lOOnM), 
significantly inhibited secretion in response to peptide. 
The N- and Q-type channel blockers, w-Conotoxins GVIA (lµM) 
and MVIIC (3µM) respectively, did not effect peptide-induced 
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Figure 1. Extracellular calcium dependence of conditioned 
media (CM) induced secretion. Values are mean ± SEM. RPMI-
1640 group represents basal chromaffin cell secretion. 
Triplicate determinations for all groups were made in each 
of 2 chromaffin cell preparations (n=6). *** = p<0.001 
compared to CM alone using an ANOVA followed by Tukey's 
comparisons. 
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Figure 2. Effect of voltage-gated calcium channel blockers 
on conditioned media (CM)-induced secretion. Concentration 
of drug used are: verapamil (lµM), w-agatoxin VIA (lOOnM), 
w-conotoxin GVIA (lµM) , and w-conotoxin MVIIC (3µM) . Values 
are mean ± SEM. RPMI-1640, basal chromaffin cell secretion, 
was 2-5% total cell content. Triplicate determinations for 
all groups were made in each of 3 chromaf fin cell 
preparations (n=9). *=p<0.05 and*** = p<0.001 respectively 
compared to CM alone using an ANOVA followed by Tukey's 
comparisons. 
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Figure 3. Effect of non-specific and L-type calcium channel 
blockers on secretion in response to the nicotinic agonist 
dimethyl phenyl piperazinium (DMPP) . Values are mean ± SEM. 
RPMI-1640 represents basal chromaffin cell secretion. Two 
triplicate determinations for all groups were made in 1 
chromaffin cell preparation (n=6). *** = p<0.001 compared 
to all other groups using an ANOVA followed by Tukey's 
comparisons. 
78 
secretion (figure 2) . The effect of non-specific and L-type 
calcium channel blockers on secretion in response to the 
nicotine agonist dimethyl phenylpiperazinium (DMPP, lOµM) 
can be seen in figure 3. 
Removal of Intracellular Calcium Sources does not Alter 
Peptide-Induced Secretion. 
The effect of removal of intracellular calcium stores 
on peptide-induced secretion was tested using dantrolene 
(30-SOµM), a membrane-permeable drug which inhibits 
intracellular calcium mobilization, and thapsigargin (0.1-
lµM) , a pharmacologic agent which depletes internal calcium 
stores. As a control, the muscarinic agonist, methacholine, 
was used to stimulate fura-2 loaded chromaffin cells in the 
presence and absence of dantrolene or thapsigargin. Both 
dantrolene and thapsigargin completely inhibited the rise in 
intracellular calcium in response to methacholine. 
Conditioned media-induced secretion, however, was unaffected 
by either dantrolene or thapsigargin treatment (figure 4) 
indicating calcium release from intracellular stores is not 
essential for peptide induced secretion. 
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Figure 4. Effect of removal of intracellular calcium on 
conditioned media (CM) induced secretion. Values are mean ± 
SEM. RPMI-1640, basal chromaffin cell secretion, was 2-5% 
in all experiments. Triplicate determinations for all 
groups were made in each of 2 chromaf fin cell preparation 
(n=6). 
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Figure 5. Rise in intracellular calcium in response to 
conditioned media (CM) stimulation is biphasic. Increased 
fluorescence ratio (F340nm:F380nm) indicates an increase in 
intracellular calcium. CM-stimulated increase in 
intracellular calcium includes an initial, fast calcium peak 
and a second, slow, sustained rise in calcium. Similar 
results were obtained in other experiments. 
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Figure 6. Time course of conditioned media induced 
secretion. Values are mean ± SEM. Basal secretion (RPMI-
1640) was subtracted from each of the time points. Two 
triplicate determinations were made using one chromaff in 
cell preparation (n=6). Similar results were obtained on 
other chromaffin cell preparations. 
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Rise in intracellular calcium in response to peptide is 
biphasic. 
Using the membrane-permeable, fluorescent calcium 
indicator, fura-2 AM, changes in chromaffin cell 
intracellular calcium in response to conditioned media 
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peptide were recorded over a sixty minute period. Figure 5 
demonstrates that CM produces an initial calcium spike 
followed by a slower, long term elevation in intracellular 
calcium levels. The biphasic nature of the intracellular 
calcium response to CM stimulation correlates temporally 
with the time course of conditioned media-induced secretion 
(figure 6) . 
Both intracellular and extracellular calcium are components 
of peptide-induced internal calcium rise. 
Fura 2-AM loaded chromaffin cells were stimulated with 
conditioned media in the presence or absence of the non-
specific calcium channel blockers cadmium (0.5mM) or cobalt 
(2.0mM). While the initial calcium spike was blunted and 
the long-term calcium increase abolished, there was still a 
significant increase in intracellular calcium in response to 
conditioned media (figures 7 & 8). Conversely, the initial 
intracellular calcium spike is significantly blunted in 
chromaffin cells incubated with thapsigargin prior to 
chromaff in cells incubated with thapsigargin prior to 
stimulation with CM (figure 9). Taken together, these 
results indicate that CM-peptide induced secretion 
stimulates both calcium influx as well as calcium release 
from internal stores. 
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Figure 7. Cadmium blocks secondary, long term intracellular 
calcium increase in response to conditioned media (CM) 
stimulation. The trace is taken from the first 5 minutes of 
a 60 minute time period. No change occurred in 
intracellular calcium between 5 and 60 minutes. An increase 
in fluorescence intensity (ratio of F340nm:F380nm) indicates 
an increase in intracellular calcium. Compared to CM alone, 
cadmium attenuates the initial, fast calcium peak and 
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Figure 8. Cobalt blocks secondary, long term intracellular 
calcium increase in response to conditioned media (CM) 
stimulation. The trace is taken from the first 5 minutes 
of a 60 minute time period. No change occurred in 
intracellular calcium between 5 and 60 minutes. An increase 
in fluorescence intensity (ratio of F340nm:F380nm) indicates 
an increase in intracellular calcium. Similar to cadmium, 
cobalt (2.0mM) attenuates the initial, fast calcium peak and 
completely blocks the second, slow, long-term calcium rise. 
Similar results were obtained in other experiments. 
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Figure 9. Thapsigargin pretreatment blunts initial 
intracellular calcium spike. The trace is of the first 3 
minutes of a 60 minute time period. No change occurred in 
intracellular calcium between 5 and 60 minutes. An increase 
in fluorescence intensity (ratio of F340nm:F380nm) indicates 
an increase in intracellular calcium. The initial calcium 
spike was significantly inhibited after thapsigargin 
pretreatment. Similar results were obtained in other 
experiments. 
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D. Discussion 
Studies have demonstrated that chromaf fin cells secrete 
catecholamine in response to a rise in cytosolic calcium 
concentration (Cheek and Thastrup, 1989; Cheek et al., 
1990). This can result from an influx of extracellular 
calcium, release from intracellular stores, or a combination 
of both. For example, nicotinic agonists induce chromaffin 
cell depolarization which leads to the opening of voltage-
gated calcium channels and subsequent calcium influx. 
Conversely, muscarinic agonists stimulate phosphoinositide 
metabolism which induces rapid accumulation of inositol 
phosphates that stimulate calcium release from intracellular 
stores. Finally, known peptide secretagogues (i.e. 
bradykinin, angiotensin II) stimulate chromaffin cell 
secretion via both extracellular calcium influx and inositol 
phosphate-activated intracellular calcium release. The goal 
of the present study was to determine if secretion in 
response to a novel, mononuclear cell-derived peptide was, 
indeed, dependent on calcium and, if so, to determine the 
importance of extracellular and/or intracellular stores. 
Initial studies addressed the role of extracellular 
calcium in peptide-induced secretion. Several inorganic 
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ions (e.g. Cd2 +, Co2 +, La 3 +) have been reported to block the 
various types of calcium channels. Evidence indicates that 
the binding site of these ions involves conserved glutamate 
residues in the proposed pore of the calcium channel 
(Hagiwara, 1981). In the present study, inhibition of 
calcium influx via one of these non-specific channel 
blockers (Co2 +) abolished conditioned media peptide-induced 
secretion (figure 1) indicating that extracellular calcium 
was essential for secretion in response to peptide 
stimulation. Further experiments were performed to assess 
the role of the voltage-gated calcium channels in peptide-
induced secretion. Bovine chromaffin cells have been 
reported to contain the L-, P-, Q-, and N-type voltage gated 
calcium channels (Lopez et al., 1989; Lopez et al., 1994) 
These channels range from high conductance (22-28pS) 
channels which inactivate rather slowly (>500 msec time 
constant) (e.g., the L-type calcium channel) to channels of 
lesser conductance (12-22pS) whose inactivation time 
constants are rather rapid (50-100 msec) (e.g., the P-, N-, 
and Q-type channels) . Specific blockers of these channel 
types were utilized to determine the relative importance of 
each channel type. While the L- and P-type channel blockers 
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(i.e. verapamil and w-Agatoxin VIA) significantly inhibited 
peptide-induced secretion, the Q- and N-type calcium channel 
blockers (i.e. w-Conotoxins GVIA and MVIIC) had no 
significant effect (figure 2). These results indicate that 
both the L- and P-type channel are involved in calcium 
influx in response to peptide but are not the only channels 
through which peptide-stimulated influx occurs. One 
potential mechanism by which these voltage gated channels 
are activated may be by depolarizing concentrations of 
calcium directly adjacent to the L- and P-type channnels. 
Upon stimulation, chromaffin cell intracellular calcium has 
been shown to range from 300-1000 nM when measuring whole 
cell calcium content. It is estimated, however, that near 
the plasma membrane (near the voltage gated calcium 
channels) , local calcium concentrations reach 10-lOOµM -
potentially great enought to lead to a local depolarization 
and activation of L- and P-type channels. Alternate 
pathways responsible for the additional calcium influx 
include IP3 /IP4 gated calcium channel(s), G-protein gated 
channel(s), a receptor gated calcium channel, or, 
potentially, activation of IcRAc (Calcium Release Activated 
Calcium current) in response to emptying of intracellular 
stores. 
Although these data do not agree with recent reports 
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(Lopez et al., 1994) which indicate that Q- and L-type 
channels are the predominant calcium channels involved in 
bovine chromaffin cell secretion, they are not surprising. 
First, the time course of CM-induced secretion (90 minutes) 
is obviously much longer than the time constants of 
inactivation for these voltage gated channels indicating a 
role for other channel types. Furthermore, studies 
performed by Lopez et al. (1994) utilized depolarizing 
concentrations of potassium to stimulate chromaff in cell 
secretion. Secretion in the present study, however, is in 
response to a mononuclear cell-derived peptide. Whereas the 
L-type channel blockers, such as verapamil, are well 
documented inhibitors of catecholamine release in response 
to high K+ (Boarder et al., 1987; Fonteriz et al., 1987), 
secretion in response to known chromaff in cell peptide 
secretagogues such as bradykinin have been shown to be 
unaffected by the presence of L-type calcium channel 
blockers (Owen et al., 1989). The difference between high 
K+ and bradykinin sensitivity to L-channel blockers indicate 
that these agents stimulate calcium entry via separate 
routes (i.e., IP3 /IP4 gated, receptor gated, or G-protein 
gated channels or IcRAc) . Potentially, the immune-derived 
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peptide in this study stimulates calcium influx through non-
L-type calcium channels similar to bradykinin. 
The role of intracellular calcium stores in peptide-
induced secretion was addressed in these studies via the use 
of two pharmacologic agents - dantrolene, which blocks 
calcium release from internal stores, and thapsigargin, 
which depletes intracellular calcium stores. Neither 
dantrolene nor thapsigargin altered chromaffin cell 
epinephrine secretion in response to peptide (figure 4) . 
Although these results indicate that intracellular calcium 
is not essential for peptide-induced secretion, they do not 
exclude the release of calcium from these internal stores in 
response to peptide stimulation. 
Further studies are presented which utilized the 
ratiometric fluorescent calcium dye, fura-2 AM, to 
temporally resolve the intracellular calcium rise in 
response to peptide. The kinetics of intracellular calcium 
changes as well as epinephrine secretion in response to 
peptide stimulation was shown to be biphasic in nature 
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(figures 5 & 6) similar to the potent chromaffin cell 
secretagogue, histamine. Both antagonist and 
desensitization studies confirm, however, that the 
stimulatory effect of conditioned media cannot be attributed 
solely to histamine. While pretreatment with histamine (100 
µM, 10 min.) did not effect CM-induced secretion from the 
same chromaffin cells, chromaffin cell histamine 
desensitization significantly inhibitted secretion in 
response to a second challenge with histamine (CM=l9.2±0.3, 
CM/histamine pretreatment=lB.4±0.7, histamine=lS.5±0.9, 
histamine/histamine pretreatment=2.4±0.2***, basal 
secretion=l.6±0.2; ***=p<0.001 vs histamine/no 
pretreatment). 
Evidence is also presented in this study which 
demonstrates the non-specific calcium channel blockers Co2 + 
(2.0rnM) and Cd2 + (O.SmM) used in conjunction with 
conditioned media diminish the initial calcium peak and 
completely abolished the delayed, maintained rise in 
intracellular calcium (figures 7 & 8). Conversely, the 
initial calcium spike in response to conditioned media was 
signf icantly reduced in chromaff in cells incubated with 
thapsigargin prior to stimulation with CM (figure 9). These 
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data indicate that while the secondary, maintained calcium 
elevation is due solely to extracellular influx, the initial 
calcium peak can be attributed to both calcium influx and 
release from internal stores. Calcium release from internal 
stores as well as influx from the extracellular environment 
in response to conditioned media peptide is 
characteristically similar to catecholamine secretion in 
response to other known peptides (e.g. bradykinin, 
angiotensin II, etc). 
In summary, the data obtained in these studies strongly 
support current concepts of epinephrine secretion in 
response to peptide secretagogues from bovine chromaff in 
cells. Conditioned media peptide-induced secretion appears 
to utilize calcium regulated signal transduction mechanisms 
that are analogous to other known peptide secretagogues. 
Similar to bradykinin and angiotensin II (Owen et al., 1988; 
Plevin and Boarder, 1988), the peptide in the present study 
appears to stimulate both release of calcium from internal 
stores as well as extracellular influx. The dependence on 
extracellular calcium for secretion is common to both the 
conditioned media peptide and other peptide secretagogues. 
Additionally, the biphasic, maintained rise in intracellular 
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calcium in response to conditioned media peptide and the 
efficacious stimulatory effect of conditioned media peptide 
agree with studies which show that the more efficacious 
chromaffin cell secretagogues (e.g. histamine) stimulate 
long-term increases in intracellular calcium (Noble et al., 
1988; Goh and Kurosawa, 1991). 
CHAPTER V 
MONONUCLEAR CELL ORIGIN OF A NOVEL PEPTIDE 
MEDIATING PERIPHERAL EPINEPHRINE SECRETION 
A. Introduction 
The role of stress in illness has been debated for many 
years. Although numerous observations have been documented 
over the centuries which note a relationship between 
stressful periods in life and subsequent illnesses, 
definitive physiologic evidence of such a relationship has 
been difficult to obtain since both psychological 
(cognitive) and physical (non-cognitive) stimuli may 
contribute to physiologic stress. The idea that mental and 
physical health are interdependent can be found in early 
medicine in the works of Aristotle. This concept was 
further promoted by Galen when he observed that melancholic 
women were more likely to develop cancer than there more 
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confident and vital counterparts (Kort, 1994). Similar 
associations between emotional stress and health appear even 
in current studies. For instance, studies site that job 
strain has a negative impact on health (Lerner et al., 
1994). There is also evidence of a correlation between a 
positive mental state and better health in terminal AIDS 
patients (Kendall, 1994). 
One of the many difficulties in ascertaining a 
physiologic connection between stress and illness is in the 
definition of "stress". The term "stress" is defined in the 
context of research and pathophysiology as "the reactions of 
the body to forces of a deleterious nature, infections and 
various abnormal states that tend to disturb its normal 
physiological equilibrium (homeostasis)" (Burgess, 1987). 
This definition requires that not only the reactions of the 
body to physical/psychological stimuli but also the stimuli 
themselves be considered the "stress". This is problematic 
when designing experimental protocols to determine the 
stress-illness relationship since both physical and 
psychological parameters are involved (Selye, 1980). 
Fortunately, experiments in animals as well as in humans 
indicate that one of the prominent underlying causes of both 
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dyshomeostasis is changes in the neuroendocrine system which 
modulates immune system function (Sheridan et al., 1994). 
Key factors of this neuroendocrine immunomodulation appear 
to be the pituitary and adrenal gland hormones, including 
the catecholamines. 
The catecholamines, epinephrine (released mainly from 
the adrenal medulla) and norepinephrine (released mainly 
from sympathetic nerve terminals) , are pivotal regulators of 
many physiological events in man. Documented actions of 
the catecholamines include the aforementioned modulation of 
immune function, a cardiac excitatory action, metabolic 
actions, and peripheral actions specific to certain muscle 
groups. In 1929, Sir Walter Cannon first associated various 
physiologic changes with increased circulating catecholamine 
(largely epinephrine) in his discussion of the "fight or 
flight'' response (Cannon, 1929). This reaction occurs when 
animals, including man, perceive danger (cognitive stimuli) 
and prepares the animal to respond through either direct 
conflict ("fight") or escape ("flight") . However, it is 
clear that stimuli not recognized directly by the central 
and peripheral nervous systems and for which there is no 
conscious perception also may lead to increased circulating 
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catecholamine and subsequent associated physiologic changes. 
Such stimuli are referred to as non-cognitive stimuli and 
include bacteria, tumors, viruses, and antigens. 
Although there are many potential mediators, the exact 
mechanism by which non-cognitive factors modulate 
neuroendocrine functions such as catecholamine release is 
not yet clear. Hypothalamic-pituitary-adrenal axis 
activation occurs as a central response to non-neurogenic 
mediators. Equally important may be peripheral release of 
stress hormone in response to a local non-cognitive stimuli. 
Recent investigations provide evidence of one potential 
mechanism by which tumors, bacteria, etc, may elicit the 
release of the stress hormone epinephrine through 
immunologic mediators. An immune-derived peptide (MW<3,000) 
released from mononuclear cell populations has been shown to 
stimulate adrenal medullary chromaff in cell epinephrine 
secretion to levels comparable to maximal neural 
stimulation. The exact mononuclear cell source of this 
peptide, however, has yet to be determined. The present 
study was performed to determine which mononuclear cells may 
potentially release bioactive peptide. Such information may 
provide insight as to the potential role of this peptide and 
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subsequent irnrnune-neuroendocrine interactions in both health 
and disease. 
B. Materials and Methods 
Primary Cultures of Chromaffin Cells 
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Isolation and Culture: Adult bovine adrenal glands were 
used for chromaff in cell isolation according to the overall 
procedure described by Dahmer et al., (1990). In brief, 
adrenal glands were perfused with collagenase, incubated at 
37°C and medullary tissue removed for further digestion. 
Digested cells were washed, counted, and viability 
determined with trypan blue staining. Purity was assessed 
using neutral red as described by Role and Perlman (1980) 
Cells were plated on collagen-coated 24-well plates at a 
density of 3Xl0 5 cells per cm2 and media was changed after 
the first day and then as needed to maintain a normal pH. 
In vitro Model of Catecholamine Secretion: Basic 
secretion experiments are similar to those described by 
Dahmer et al., (1990). In brief, growth media was removed 
from each well and replaced with conditioned media, serum-
free RPMI-1640, Earle's Balanced Salts Solution (EBSS), or 
secretagogue in EBSS. After incubation, media was removed 
and saved. Catecholamine content in these samples represent 
that stimulated by conditioned media (90 minute incubation), 
spontaneous/basal secretion (RPMI/EBSS, 90 minute 
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incubation) , or that stimulated by a known secretagogue 
(DMPP/55mM K+, 10 minute incubation) in the presence or 
absence of drug/channel blocker. Cells were then lysed by 
adding lM perchloric acid and the acid saved for 
determination of the remaining cellular epinephrine 
content. Epinephrine secreted into the media as a percent 
of total content was calculated by dividing the amount 
secreted by the total well content. Secretion experiments 
were routinely done in triplicate using three separate wells 
on any one plate all of which were derived from the same 
adrenal gland. Replicates of separate triplicate 
determinations were made on cells from different chromaff in 
cell preparations. Analysis of epinephrine was accomplished 
with HPLC using electrochemical detection. Mobile phase 
contained O.lM monochloroacetic acid with O.SmM EDTA and 
l.OmM sodium octyl sulfate adjusted to pH 3.0. Acetonitrile 
was added at 15ml/L. A BAS Liquid Chromatography System 
including an LC 4C amperometric detector and glassy carbon 
electrode was used in all analyses. 
Primary Cultures of Mononuclear Cells from Spleen 
Isolation and Culture: Whole bovine spleen was 
obtained from a local slaughter house. Inner spleen tissue, 
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which includes both red and white pulp, was dissected out, 
cut into small pieces and forced through wire mesh in Hank's 
Balanced Salts Solution (HBSS) at room temperature. Crude 
cell suspensions were layered on density gradient media 
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and 
then separated. Isolated cells were washed, viability 
assessed using Trypan Blue, and cells were then transferred 
to flasks with RPMI media containing only essential amino 
acids and antibiotics. The growth media was isolated from 
the cells after at least 24 hours of culture and either used 
promptly or frozen (-20°C). 
Separation of Monocyte/Macrophage Populations: The 
monocyte/macrophage populations were isolated from other 
splenocytes based on 1 hour adherence to plastic in culture 
flasks at 37°C (Clarke et al., 1993). Purity of the 
monocyte/macrophage cultures was assessed using two 
different staining methods. Wright-Giemsa staining was used 
to ensure no other adherent cell populations (i.e. dendritic 
cells, fibroblasts) were present in the culture. Non-
specific esterase activity, unique to monocyte/macrophage 
mononuclear cells, was used to determine contamination of T 
and B cell populations in adherent cell cultures. 
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Hybridoma Cell Lines 
IL-ASl/anti CD-8: The immortal cell line IL-ASl, a 
murine hybridoma cell line producing monoclonal antibody 
(IgGl) to the bovine orthologue of human CDS, was obtained 
from American Type Culture Collection (ATCC, Rockville, MD). 
Cells were cultured at the concentration of 106 cells/ml in 
a media comprised of RPMI-1640 supplemented with 10% (v:v) 
fetal bovine serum and 20µM 2-Mercaptoethanol. Cultures 
were maintained by adding fresh media every 2-3 days as 
needed. 
IL-All/anti CD-4: The immortal cell line IL-All, a 
murine hybridoma cell line producing monoclonal antibody 
(IgG2a) to the bovine orthologue of human CD4, was obtained 
from American Type Culture Collection (ATCC, Rockville, MD). 
Cells were cultured at the concentration of 106 cells/ml in 
RPMI-1640 supplemented with 10% fetal bovine serum and SOµM 
2-Mercaptoethanol. Cultures were maintained by the addition 
of fresh media every 2-3 days as necessary. 
T cell/B cell Isolation and Separation Using Monoclonal 
Antibodies 
Isolation of Antibody from Hybridoma Cultures: 
Hybridoma cultures were allowed to grow until culture media 
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was turbid. The hybridoma cell culture flask was then 
agitated, lysing cells and maximizing antibody concentration 
in the suspension. Cell suspension was then centrifuged at 
2000g at 4°C to sediment large proteins and cell membrane. 
The supernatant was poured over a Proteins A/G column, 
bacterial products that bind the Fe portion of the antibody, 
and purified antibody was eluted from the column using O.lM 
glacial acetic acid (pH=2.0). Absorbance at 206nm of column 
effluent was used to indicate antibody elution. 
Antibody Biotinylation and Coupling to Magnetic 
Microbead: Antibody was conjugated with magnetic microbeads 
using the avidin-biotin system. Briefly, antibody was 
dialyzed against O.lM NaHC03 (pH=8.4) overnight and 
concentration after dialysis determined via spectrophometric 
analysis using the Bradford assay. Antibody was then 
concentrated or diluted to obtain a final concentration of 1 
mg/ml. Immediately before use, 1.63 mg of NHS-LC-biotin 
(Pierce, Rockford, IL) was dissolved in 1 ml of dimethyl 
sulfoxide (DMSO) in a glass tube. This mixture was 
triturated and 50 µl is added to 1 ml antibody solution. 
This procedure results in a biotin substitution ratio of 
approximately 8:1. The reaction was allowed to proceed at 
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room temperature for one hour. The reaction mixture was 
then dialyzed against O.lM NaHC03 for 48 hours. Sodium 
azide, a cytotoxic substance which protects antibody 
integrity, was not used since antibody labeled cells will be 
maintained in culture for an extended period (24-48h). 
Magnetic-based Cell Separation: Biotinylated antibody, 
anti CD4 or anti CDS, was added to the lymphocyte cell 
suspension for 10 min to allow for adequate labeling with 
antibody and unbound/excess antibody was removed by three 
washes in cold phosphate buffered saline (PBS) (pH=7.4). 
Biotinylated antibody, bound to its respective cell surface 
marker, was then coupled to a streptavidin linked magnetic 
microbead during a 10 min incubation on ice, a reaction 
which occurs due to the high affinity of streptavidin for 
biotin (Kd=10- 19M) . Cells were washed again in cold PBS and 
labeled cells passed over a magnetic column. In theory, all 
cells labeled with magnetically-conjugated antibody should 
have been retained on the column while any unlabeled cells 
would pass through. Labeled cells, still bound to magnetic 
beads, can then be extruded from the column by removing the 
column from the magnetic field and washing several times in 
cold PBS. These cells, still labeled with antibody, may 
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then be cultured according to standard conditions. This 
protocol was followed twice for each lymphocyte preparation, 
one passage to remove CD4 positive lymphocytes and a second 
to remove CDS positive lymphocytes. B cells were considered 
to be those populations which were not labeled by 
magnetically linked antibody and thus washed through the 
column. The purity of the cell cultures was ascertained 
using FACS analysis and determined to be between 80% and 
90%. 
G-25 Sephadex Column Gel Filtration 
G-25 Sephadex beads (10 g) were combined with deionized 
water at a ratio of 1 g per 2-3 ml water yielding a final 
volume of approximately 30 ml and equilibrated for 8-10 
hours. This volume was placed in a 2 cm column which was 
attached to a continuous perfusion pump with a loop 
containing an injection valve and equilibrated with 
phosphate buffered saline (PBS, pH 7.2). Conditioned media 
(2 ml) from individual cell cultures was introduced using 
the loop. The molecular weight standard Blue Dextran (MW 
2Xl0 6 ) was totally excluded from the beads and provided a 
measure of the void volume. Potassium chromate (MW 194) 
totally penetrates the Sephadex beads and was used to 
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reflect the total volume. Fraction collection (2 ml each) 
began when the void volume was eluted and continued until 
the total volume was removed from the beads. Absorbance at 
206nm was measured as the fractions were eluted from the 
column and was used to indicate the presence of peptide. 
Polyacrylamide Gel Electrophoresis (PAGE) 
Basic methods were similar to those described by 
Schagger and von Jagow (1987) . In brief, a 20% T separating 
gel was prepared containing 3.0 M Tris (pH 8.45) and 
glycerol. This was overlaid with a 10% spacer gel, followed 
by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding a gel 
with approximate dimensions of 0.75mm X 6.5cm X 9.5cm. A 
discontinuous buff er system was utilized which included a 
Tris-base (pH 8.9) anionic buffer and a Tricine/Tris 
cationic buffer. Approximately 20µg of sample was loaded 
into each lane and a constant voltage was applied to the gel 
(20V for 1 hour followed by lOOV for 1.5 hours). The gel 
was removed from the apparatus once the dye front reached 
the anionic buffer-gel interface and stained with silver. 
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C. Results 
Bioactive peptide is a product of viable mononuclear cells. 
Viability of mononuclear cells isolated from bovine 
spleen was determined at the time of isolation then at 24 
and 48 hours post-isolation using trypan blue. Figure 10 
demonstrates that over this time course viability decreases 
significantly at each time point. Over this same time 
course the bioactivity of conditioned media harvested from 
these mononuclear cell cultures also diminished (figure 11) 
indicating that the bioactive peptide was a viable cell 
product. 
Nonadherent T and/or B cell populations are the main 
mononuclear cell source of bioactive peptide. 
Mononuclear cells were separated based on 1 hour 
adherence to plastic at 37°C. Adherent monocyte/macrophage 
cell populations and nonadherent T cell and B cell 
populations were cultured separately for 24 hours then the 
CM was harvested and, using Centricon filters, molecules 
>3,000 MW were removed. Figure 12 shows that only the CM 
from the nonadherent cell cultures stimulated significant 
epinephrine release from primary chromaffin cell cultures 
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TimeO 24h 48h TimeO 24h 48h 
Spleen #1 Spleen #2 
Figure 10. Mononuclear cell viability decreases between 24h 
and 48h post-isolation. The number of viable cells in 
culture were determined based on exclusion of trypan blue. 
Results shown are two separate splenocyte preparations. 
Similar results were obtained in three other preparations. 
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Media (CM) Media (CM) Media (CM) Media (CM) 
Spleen #1 Spleen#2 
Figure 11. Conditioned media bioactivity decreases as 
mononuclear cell viability decreases. Values given are the 
mean ± SEM from the two different splenocyte preparations 
utilized in figure 1. Each bar represents 2 triplicates 
from one chromaffin cell preparation (n=6). 
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Figure 12. Nonadherent T cell and B cell conditioned media 
exhibits the majority of bioactivity. Values are the mean ± 
SEM from triplicates of two different chromaf fin cell 
preparations (n=6). ***=p<0.01 compared to conditioned 
media (CM) . Statistics utilized an ANOVA followed by a 
Tukey's follow up comparison. 
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indicating that these populations are the primary source(s) 
of bioactive peptide. 
CD4+ cell conditioned media exhibits the majority of 
bioactivity. 
Nonadherent cell populations were separated into CD4+ 
or CDS+ T cell populations and B cell populations using 
magnetic based cell separation. A bioassay of CM harvested 
from each of these populations revealed that only the CD4+ 
(T helper) cell CM exhibited any significant bioactivity 
(figure 13). Concurrently, to determine if contact between 
different cell populations was necessary to observe maximal 
bioactivity, cell populations were recombined and cultured 
in various combinations subsequent to separation. No 
significant difference was observed between the bioactivity 
of single cell population CM and CM from recombined cell 
cultures (data not shown) . 
T helper and B cell populations are potential sources of 
bioactive peptide. 
Conditioned media from CD4+, CDS+, and B cell cultures 
was purified using a G-25 Sephadex column. Based on results 
from previous studies, fractions were pooled into groups 
which potentially contained bioactive peptide and those 
which did not. Samples from each pooled group (20µg peptide 
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which did not. Samples from each pooled group (20µg peptide 
in each) were run on a polyacrylamide gel to determine if 
bioactive peptide was present in CM from each population. 
Figure 14 shows that both the CD4+ and B cell populations CM 
contained bioactive peptide while no peptide was found in 
CDS+ cell CM. 
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Figure 13. T helper cell conditioned media possesses the 
majority of bioactivity. RPMI-1640 represents basal 
chromaffin cell secretion. Values are the mean ± SEM from 2 
preparations from each of 2 splenocyte preparations (n=4). 
This media was then utilized in secretion experiments 
performed in triplicate on two chromaff in cell preparations 
(n=6). *=p<0.05 compared to conditioned media (CM) using an 
ANOVA and Tukey's follow up comparisons. 
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Lane 1 2 3 4 5 
Figure 14. Bioactive peptide is produced by T helper (CD4+) 
and B cell populations. Samples in each lane are: Lane 1 = 
CD4+ cell CM, fractions MW<3,000; Lane 2 = CDS+ cell CM, 
fractions MW<3,000; Lane 3 = B cell CM; fractions MW<3,000; . 
Lane 4 = Nonadherent Cell CM, Fractions MW <3,000; Lane 5 = 
enriched bioactive peptide isolated from total mononuclear 
cell cultures. The CD4+, B cell and nonadherent cell 
conditioned media all contain peptide of interest while 
there is no evidence of the band in CDS+ CM. 
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D. Discussion 
As research in the area of neural-immune interaction 
progresses, it is becoming clear that the immune system and 
neuroendocrine system have the capacity to communicate with 
each other via common signal molecules and common receptors 
(Carr and Blalock, 1991) . Central to this bidirectional 
communication is production of classic neuropeptide hormones 
by cells of immune origin. The first evidence that 
leukocytes could synthesize functional neuroendocrine 
hormones was obtained from studies which demonstrated that 
during the production of interferon alpha (IFNa), virally-
challenged human leukocytes coexpressed a peptide which was 
antigenically related to the pituitary hormone, 
adrenocorticotropin (ACTH) (Smith and Blalock, 1981) This 
immune-derived ACTH was similar to its pituitary counterpart 
with respect to its antigenicity, molecular weight, and 
retention time on high pressure liquid chromatography 
(HPLC) . This leukocyte-derived ACTH was shown to have the 
same amino acid sequence as pituitary-derived ACTH, 
originate from the same precursor, proopiomelanocortin 
(POMC), in immune cells as in the pituitary gland (Smith et 
al., 1982), and have similar biological activity (Clarke et 
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al., 1982), and have similar biological activity (Clarke et 
al., 1993) . 
Recent investigations have expanded the list of 
hormones and neuropeptides produced by immune cells to 
include thyrotropin (TSH) (Smith et al., 1983), chorionic 
gonadotropin (CG) (Harbor-McMennamin et al, 1986), growth 
hormone (GH) and prolactin-related peptides (Hiestand et 
al., 1986), somatostatin (Lygren et al., 1984; Goetzl et 
al., 1985), luteinizing hormone (LH) (Emanuele et al., 
1990), and vasoactive intestinal peptide (VIP) (Lygren et 
al., 1984), among others. Although the biological relevance 
of immune cell production of such molecules is not yet fully 
understood, in vitro experimentation indicates these 
hormones and neuropeptides have the capacity to modulate 
both neuroendocrine and immune functions (Koff and Dunegan, 
1985; Mercola et al., 1981; Snow, 1985; Payan et al., 1986) 
Previously, we have demonstrated that yet another immune-
derived peptide may be added to this list of potential 
immune-neuroendocrine signalling molecules. This small 
peptide (MW<3,000) is released from mononuclear cells (MNC) 
and has been shown to stimulate adrenal medullary chromaf fin 
cell epinephrine secretion to levels comparable to maximal 
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cholinergic stimulation (Jones et al., 1993). 
Since all MNC used in these experiments are cultured in 
the absence of serum to omit serum-derived growth factors in 
the bioassay system, tests were performed to ensure that 
serum-free conditions did not alter MNC cell viability. 
Potentially, a decrease in viability might imply that the 
bioactive component of CM was a MNC death product. Figures 
10 and 11 clearly show this is not the case. Although MNC 
viability does decrease as time in culture increases (figure 
10), bioactivity of CM harvested over the given time course 
also decreases (figure 11) . If the bioactive peptide were a 
product of MNC death, one would expect bioactivity to 
increase as viability decreased. 
Further data are presented which demonstrate potential 
sources of this mononuclear cell peptide. Interestingly, 
just as cytokine production is unique to specific immune 
cell populations, investigations have revealed that not all 
immune cells are capable of producing all neuropeptides and 
hormones. For example, in cell cultures stimulated with 
endotoxin, B cells, but not T cells synthesize and release 
bioactive ACTH and endorphin (Harbour et al., 1991). 
Activated CD4+ T lymphocytes, however, appear to be the 
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source of opioid peptide in cultures stimulated with the 
pineal neurohormone melatonin (Maestroni and Conti, 1991). 
The present studies provide evidence that the immune cell 
source of the small bioactive peptide is also specific. 
Initial results demonstrate that when MNC populations are 
separated based on adherence to plastic, the non-adherent T 
cell and B cell populations exhibit the majority of 
bioactivity (figure 12). Further separation of these non-
adherent cell populations using specific cell surface 
markers revealed that while the CD4+ (T helper) cell CM 
possessed the majority of bioactivity (figure 13), both the 
CD4+ cell and the B cell are potential sources of the 
bioactive peptide (figure 14). Peptide production by the 
CD4+ and B cell populations in the present study, unlike 
previously cited works, occurs without mitogenic 
stimulation. This finding is not surprising in that Kol et 
al., (1983) demonstrated that both mechanical stimulation 
and stimulation by density centrifugation media, as would 
occur during cell isolation, will activate mononuclear 
cells. This suggests that mononuclear cell isolation in the 
present study is a sufficient stimulus for mononuclear cell 
bioactive peptide production. 
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Identification of specific immune cell source(s) of the 
neuropeptides and hormones will provide insight into the 
physiologic significance of immune cell production of these 
substances. This information will also aid in understanding 
certain aspects of a pathophysiology or disease state based 
on an immune cell-specific peptide/hormone. For example, 
lymphocyte-derived CG has been speculated to be an important 
suppressive factor necessary for a successful implantation 
of the blastocyst and, ultimately, a successful pregnancy 
(Blalock, 1994). In this instance a deficiency of immune 
cells that normally produce this CG may be a causative 
factor contributing to infertility. Similarly, deficiency 
or dysfunction of CD4+ and/or B cell populations, as in 
cases of Acquired Immune Deficiency Syndrome (AIDS) or 
Severe Combined Immunodeficiency (SCID) , may lead to 
subsequent alterations in bioactive peptide production. The 
lack or dysfunction of cell sources of the bioactive peptide 
in these patient populations may have serious ramifications 
in communications between the immune and neuroendocrine 
systems. Modifications in peptide release would potentially 
impact non-neurogenic catecholamine secretion. The 
implications of this altered neuroendocrine function, 
however, remain to be elucidated. Further studies 
addressing the role of this peptide in homeostatic 
mechanisms may help explain specific physiologic 
abnormalities when the function of peptide-cell sources 
(CD4+, B cell) are impaired. 
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CHAPTER VI 
MONONUCLEAR CELL PEPTIDE MEDIATION OF CHROMAFFIN CELL 
EPINEPHRINE SECRETION 
A. Introduction 
Identification of informational molecules common to the 
central nervous system and the immune system such as 
cytokines, hormonesi and neuropeptides provides molecular 
evidence for bidirectional communication between these 
systems (Weigent et al., 1990; Arnason et al., 1991; 
Epstein, 1993). Examples of signalling molecules include 
the cytokines tumor necrosis factor-a, interleukin-1, and 
interleukin-6 which have been shown to be potent modulators 
of the hypothalamic-pituitary-adrenal axis (Imura et al., 
1991). Additionally, interleukin-1 has been shown to 
enhance sympathetic nerve activity (Haefli et al., 1993; 
Ichijo et al., 1994), modify the neuronal gene expression of 
molecules such as substance P (Jonakait, 1993), and is 
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synthesized and released by cultured sympathetic neurons 
(Frieden et al., 1992). Current literature indicates that 
immune-derived peptides may also play a role in modulating 
neural/endocrine function. In 1981, Blalock and Smith were 
the first to report that human peripheral blood lymphocytes 
(PBL) infected with Newcastle disease virus (NDV) produced 
the proopiomelanocortin (POMC)-derived peptides, 
adrenocorticotropin (ACTH) and Beta-endorphin (Smith et al., 
1981; Smith et al., 1982; Clarke et al., 1993) 
Interestingly, in studies with mice previously 
hypophysectomized to eliminate the pituitary as a source of 
ACTH, challenge with NDV significantly elevated plasma 
corticosterone levels (Smith et al., 1981; Smith et al., 
1982; Clarke et al., 1993). Furthermore, glucocorticoids 
released in response to immunoreactive-ACTH were shown to 
negatively feedback on the immune cells to prevent further 
release of ACTH or endorphin. Thus, products of the immune 
system were found to affect output from the adrenal cortex. 
Although many details of immune cell-derived ACTH 
sequences and processing are recognized (Smith et al., 
1990), such immune cell influences on classic stress 
hormones appear to be confined to the adrenal cortex. As of 
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this date there is little evidence that immune cells can 
influence the release of the other classic stress hormone 
epinephrine, from the adrenal medulla. In contrast, there is 
abundant clinical and experimental evidence that infectious 
challenge, which activates immune cells, results in profound 
epinephrine release which may serve important compensatory 
functions to maintain homeostasis (Benedict and Grahame-
Smith, 1978; Jones et al., 1988). Although increased 
central sympathetic outflow is known to mediate such 
epinephrine release (Jones et al., 1988), recent evidence 
from this laboratory has shown that non-neural release of 
epinephrine during simulated infectious challenge can 
contribute approximately 30% of total circulating 
epinephrine (Zhou and Jones, 1993). In light of these 
facts, initial experiments were conducted to test the 
possibility that immune cells could mediate epinephrine 
release using an in vitro system (Jones et al., 1993). 
These experiments using conditioned media from mononuclear 
cells, suggested that a small molecular weight (<3,000) 
product(s) of mononuclear cells can cause epinephrine 
release from chromaff in cells and that classic nicotinic and 
muscarinic neural receptors were not involved. The goal of 
125 
the present study was to elucidate the physical and 
biochemical properties of the immune cell-derived product 
and determine if a feedback loop exists. The present study 
provides significant new information about this factor from 
mononuclear cells in regard to the specificity of immune 
cell-mediated epinephrine secretion. Most importantly, 
electrophoretic experiments suggest that this epinephrine 
secretion involves the action of a small molecular weight 
peptide. The present work clearly demonstrates the 
potential for circulating immune cells to produce a peptide 
which can cause epinephrine release from the adrenal 
medulla. This immune-derived peptide may play a role in the 
non-neurogenic epinephrine release in response to infectious 
challenge and other stressors. 
B. Materials and Methods 
Primary Cultures of Chromaffin Cells 
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Isolation and Culture: Adult bovine adrenal glands were used 
for chromaf fin cell isolation according to the overall 
procedure described by Dahmer et al., (1990). In brief, 
adrenal glands were perfused with collagenase, incubated at 
37°C and medullary tissue removed for further digestion. 
Digested cells were washed, counted, and viability 
determined with trypan blue staining. Purity was assessed 
using neutral red as described by Role and- Perlman (1980) 
Cells were plated on collagen-coated 24-well plates at a 
density of 3X10 5 cells per cm2 and media was changed after 
the first day and then as needed to maintain a normal pH. 
In vitro Model of Catecholamine Secretion: Basic secretion 
experiments are similar to those described by Dahmer et al., 
(1990). In brief, growth media was removed from each well 
and replaced with conditioned media, serum-free RPMI-1640, 
Earle's Balanced Salts Solution (EBSS), or secretagogue in 
EBSS. After incubation, media was removed and saved. 
Epinephrine content in these samples represent that 
stimulated by conditioned media (90 minute incubation), 
spontaneous/basal secretion (RPMI/EBSS, 90 minute 
incubation) , or that stimulated by a known secretagogue 
(DMPP/55mM K+, 10 minute incubation) in the presence or 
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absence of drug/channel blocker. Cells were then lysed by 
adding lM perchloric acid and the acid saved for 
determination of the remaining cellular epinephrine content. 
Epinephrine secreted into the media as a percent of total 
content was calculated by dividing the amount secreted by 
the total well content. Secretion experiments were 
routinely done in triplicate using three separate wells on 
any one plate all of which were derived from the same 
adrenal gland. Replicates of separate triplicate 
determinations were made on cells from different chromaff in 
cell preparations. Analysis of epinephrine was accomplished 
with HPLC using electrochemical detection. Mobile phase 
contained O.lM monochloroacetic acid with 0.5mM EDTA and 
l.OmM sodium octyl sulfate adjusted to pH 3.0. Acetonitrile 
was added at 15ml/L. A BAS Liquid Chromatography System 
including an LC 4C amperometric detector and glassy carbon 
electrode was used in all analyses. 
Primary Cultures of Superior Cervical Ganglion (SCG) Cells 
Cell Isolation and Culture: Methods are as those 
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described previously (Wang et al., 1995). Briefly, superior 
cervical ganglia were dissected from fetal pigs (size: 15-20 
cm, gestation age: 6.5-10 weeks) obtained from the local 
slaughterhouse. The surrounding tissue was carefully 
removed and the ganglia were transferred to a 0.2% 
collagenase-A solution. After gently stirring for 30 min at 
37°C, the ganglia were transferred to a fresh collagenase 
solution. The cell suspension was centrifuged (200Xg; 4 
min). The pellet, containing the dissociated cells was 
resuspended in culture medium (Nutrient Mix HAM Fl2) 
supplemented with 10% (v/v) horse serum, 1 µg/ml insulin, 1 
µg/ml transferrin, 30 ng/ml nerve growth factor, and 
antibiotics. This procedure was repeated several times 
until all tissue was digested. The dissociated cells were 
submitted to a differential plating for 2 hours in order to 
remove most of the non-neuronal cells. The cells were 
counted in a Coulter counter and plated out at the density 
of 2Xl0 4 cells/cm2 in culture flasks or 
polyornithine/laminin coated 24 well plates. Cultures were 
maintained at 37°C in a humidified incubator under an 
atmosphere of 95% 0 2 and 5% C02 • The medium was changed 
every 72 hours. 
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In Vitro Model of Catecholamine Secretion: Superior 
cervical ganglia cells were loaded with [3H]norepinephrine 
for 2 hours, washed extensively (one 30 min. wash followed 
by three 15 min washes), then exposed to conditioned media 
or serum-free RPMI-1640 for 90 minutes. Media was harvested 
and supernatant radioactivity and the remaining 
radioactivity in each well was determined using the TRI-CARB 
460 system (Packard, USA) . Norepinephrine secreted into the 
media as a percent of cell content was calculated as 
radioactivity of the supernatant divided by total 
radioactivity of the cells in the well. 
Digitonin Permeabilization of Chromaffin Cells: 
Chromaf fin cells were plated according to described methods 
in 24 well plates at 10%, 20%, 40%, 50%, 60%, 80%, 90%, and 
100% of the normal/maximal density (6Xl0 5 chromaffin 
cells/well) . All experiments were performed in triplicate 
on each chromaffin cell preparation. Digitonin (20µM) was 
added to each of the wells and allowed to incubate for 20 
minutes. Supernatant from each well was then harvested and 
assessed for catecholamine content using HPLC or for lactate 
dehydrogenase activity as described below. 
Measurement of Lactate Dehydrogenase Activity in Cell 
Supernatant 
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Lactate dehydrogenase (LDH) activity of chromaffin cell 
supernatant was determined using the LDH procedure #500 from 
the Sigma Chemical Co. (St. Louis, MO). Briefly, 40 µl of 
supernatant was added to a cuvette containing 1 ml of the 
LDH substrates pyruvate and NADH in phosphate buffered 
saline (PBS) . Absorbance of this solution at 340 nm was 
measured each minute for three minutes and the mean change 
in absorbance calculated. LDH activity (U/L) for each 
sample was calculated according to the manufacturer's 
instructions. 
Primary Cultures of Mononuclear Cells from Spleen 
Isolation and Culture: Whole bovine spleen was 
obtained from a local slaughter house. Inner spleen tissue, 
which includes both red and white pulp, was dissected out, 
cut into small pieces and forced through wire mesh in Hank's 
Balanced Salts Solution (HBSS) at room temperature. Crude 
cell suspensions were layered on density gradient media 
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and 
then separated. Isolated cells were washed, viability 
assessed using Trypan Blue, and cells were then transferred 
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to flasks with RPMI media containing only essential amino 
acids and antibiotics. The growth media was isolated from 
the cells after at least 24 hours of culture and either used 
promptly or frozen (-20°c). 
Characterization of Bioactive Components of Conditioned 
Media 
Acid Hydrolysis: Conditioned media was harvested from 
24-hour mononuclear cell cultures then boiled in acid (3N 
HCl) for 30 minutes. After boiling, media was brought to 
physiologic pH, filtered (Centricon, 3,000 MW cutoff) then 
utilized in secretion experiments. 
Carboxypeptidase Y and Leucine Aminopeptidase: 
Conditioned media was harvested from 24-hour mononuclear 
cell cultures then incubated at 37°C either alone or with 
enzyme (final concentration of enzyme 25µg/ml) . After the 
specified incubation time, media ± enzyme was centrifuged 
through a Centricon filter (3,000 MW cutoff) to remove 
peptidase enzyme or other molecules larger than 3,000 MW. 
Media was either used promptly in secretion experiments or 
frozen (-20°C). 
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Peptide Purification and Isolation 
G-25 Sephadex Column Gel Filtration: G-25 Sephadex 
beads (10 g) were combined with 30 ml deionized water and 
equilibrated for 8-10 hours. This volume was poured into a 
2 cm column which was attached to a continuous perfusion 
pump and equilibrated with Phosphate Buffered Saline (PBS, 
pH=7.2). A 2 ml injection loop was used to introduce 
conditioned media onto the column with an injection valve. 
Blue Dextran (MW 2Xl0 6 ) provided a measure of the void 
volume and potassium chromate (MW 194) was used to determine 
total volume. Fraction collection (2 ml each) began when 
the void volume was eluted and continued until the total 
volume was removed from the beads. Elution of peptide was 
determined by monitoring absorbance at 206nm as the effluent 
came off the column. 
SDS-PAGE: Basic methods are similar to those described 
by Schagger and von Jagow (1987) . In brief, a 20% T 
separating gel was prepared containing 3.0 M Tris (pH 8.45) 
and glycerol. This was overlaid with a 10% spacer gel, 
followed by a 4% stacking gel (3.0 M Tris, pH=8.45) yielding 
a gel with approximate dimensions of 0.75mm X 6.5cm X 9.5cm. 
A discontinuous buff er system was utilized which included a 
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Tris-base (pH 8.9) anionic buffer and a Tricine/Tris 
cationic buffer. Approximately 20µg of protein was loaded 
into each lane and a constant voltage was applied to the gel 
(20V for lhour followed by lOOV for 1-1.5 hours). The gel 
was removed from the apparatus once the dye front reached 
the anionic buffer-gel interface and silver stained. 
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C. Results 
Mononuclear Cell Conditioned Media (CM) Stimulates 
Chromaf fin Cell Epinephrine Secretion to Levels Comparable 
to Maximal Cholinergic Stimulation. 
Figure 15 shows that mononuclear cell-derived 
conditioned media (CM) stimulates chromaffin cell 
epinephrine secretion to levels comparable to maximal 
cholinergic stimulation and that induced by depolarizing 
concentrations of potassium. Mononuclear cells used in 
these experiments were cultured in the absence of serum to 
ensure that the bioactivity of MNC media (CM) was not a 
result of serum-derived factors. 
CM - Induced Secretion Occurs through Specific, Typical 
Exocytotic Processes. 
Lactate dehydrogenase (LDH) and modulation of external 
calcium were used to determine if CM - induced secretion 
occurred through stimulation of specific exocytotic 
processes. In LDH experiments, chromaffin cells were plated 
in 24 well plates in concentrations 10, 20, 40, 50, 60, 80, 
and 90 percent of the normal conditions (6 X 10 5 
cells/well) . Cells were permeabilized with digitonin (20µM, 
Conditioned 
Media(CM) 
DMPP 
+ 
55mMK RPMI-1640 
(serum free) 
Earle's Balanced 
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Figure 15. Conditioned media-induced catecholamine secretion 
comparable to maximal cholinergic stimulation. Values given 
are mean ±SEM from triplicates of 3 to 6 different 
chromaffin cell preparations (n=9 to 18). ***=p<0.001 when 
compared to CM, control, or high potassium using an ANOVA 
comparison with Tukey's follow-up test. 
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Figure 16. Epinephrine content in media of chromaffin cells 
permeabilized with digitonin (20µM) for 20 minutes. Maximal 
cells (100%) plated per well = 6 X 10 5 in a 24 well plate. 
Values given are the mean ± SEM from triplicates of 3 
different chromaffin cell preparations (n=9) . 
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Figure 17. Lactate dehydrogenase (LDH) activity in media of 
chromaffin cells permeabilized with digitonin (20µM) for 20 
minutes. Maximal cells plated per well = 6 X 10 5 in a 24 
well plate. Values are mean ± SEM. LDH activity (U/L) 
defined as the amount of enzyme which catalyzes the 
formation of 1 µmol/L of NAD+ per minute under the 
conditions of the assay. ***=no detectable LDH activity. 
Results obtained from triplicates of 3 different chromaffin 
cell preparations (n=9) . 
20 min) then supernatant from each well was assessed for 
catecholamine content and LDH activity as previously 
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described. With this information, the relationship between 
LDH and the catecholamine content was determined. As 
figures 16 and 17 demonstrate, the greater the concentration 
of digitonin-permeabilized cells the greater the epinephrine 
content and lactate dehydrogenase activity of the 
supernatant. This can be contrasted to the LDH activity and 
catecholamine content of cells exposed to CM. The average 
catecholamine released by CM exposure (90 min) was 2.1 µg 
per well (figure 16). However, there was no detectable LDH 
activity in CM supernatant (figure 17, ***) under the given 
experimental conditions indicating that CM stimulated 
specific secretory events. Similar results were obtained 
(no detectable LDH activity, significant catecholamine 
content) from chromaffin cell media after stimulation with 
the nicotinic agonist DMPP (data not shown) . 
Classic secretory pathways in chromaf fin cells are 
intimately coupled to calcium and bovine chromaf fin cells in 
particular are dependent upon the influx of extracellular 
calcium to observe secretagogue-induced secretion. 
Therefore, the availability of external calcium was 
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Figure 18. Extracellular calcium dependence of conditioned 
media (CM)-induced secretion. Values are mean± SEM. RPMI-
1640 group represents basal chromaffin cell secretion. 
Triplicate determinations for all groups were made in each 
of 2 chromaffin cell preparations (n=6). *** = p<0.001 
compared to CM alone using an ANOVA followed by Tukey's 
comparisons. 
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Figure 19. Acid hydrolysis of conditioned media 
significantly reduces bioactivity. Values given are mean ± 
SEM from triplicate determinations in 3 chromaff in cell 
preparations (n=9). ***=p<0.001 compared to CM using an 
ANOVA and Tukey's comparisons. 
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modulated to determine if CM - induced secretion had a 
similar dependence on extracellular calcium. The influx of 
extracellular calcium was inhibited by the non-specific 
calcium channel blockers cadmium (O.lmM) and cobalt (2.0mM) 
Results presented demonstrate that both cadmium (figure 18) 
and cobalt (figures 2 & 18) reduced CM - induced secretion 
to levels near or at background indicating CM - induced 
secretion is dependent on extracellular calcium influx. 
Similar results were obtained using the nicotinic agonist 
1,1-Dimethyl-4-Phenylpiperazinium (DMPP, lOµM), a 
secretagogue known to be dependent on external calcium to 
induce secretion (figure 3). 
Evidence that Bioactive Component(s) of CM are Peptide(s) 
Evidence that the bioactive component(s) of CM are 
peptide in nature is based on acid hydrolysis, enzymatic 
treatment, as well as polyacrylamide gel electrophoresis of 
purified fractions of CM. Acid hydrolysis (3N HCl, 100°C) 
of CM for 30 minutes significantly reduced the bioactivity 
of CM (Figure 19). Similarly, carboxypeptidase Y (CY, 25 
µg/ml) treatment also significantly decreased CM 
bioactivity. As figure 20 illustrates, increasing 
incubation time with CY significantly decreased bioactivity 
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Figure 20. Secretion experiments using carboxypeptidase Y 
(CY)-treated conditioned media. Values are mean± SEM from 
triplicates of 6 chromaffin cell preparations (n=18). Data 
represent epinephrine secretion from enzyme-treated CM as a 
percent of the time-matched control (incubated, non-
enzymatically treated CM). *=p<0.05 when compared to time-
matched control using an ANOVA and Tukey's follow up test. 
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Figure 22. Bioactivity of G-25 Sephadex enriched fraQtions 
of conditioned media. Values are mean ± SEM taken f~om 
triplicates of each fraction of CM. RPMI-1640 repre~ents 
basal chromaffin cell secretion. Filtered is bioacttvity of 
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Lane 1 2 3 
Figure 23. Silver stain of a modified Schagger gel reveals a 
single peptide band in the bioactive fraction from G-25 
purified conditioned media. Lane 1 contains 20µg protein 
from total conditioned media (not filtered through Centricon 
filter), Lane 2 contains RPMI-1640 cell culture media, and 
Lane 3 the bioactive fraction from the G-25 column. 
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of CM when compared to time-matched controls. CY treatment 
did not, however, decrease CM bioactivity to background 
levels indicating that the enzymatic digestion was 
incomplete (see Discussion, pg 154). Treatment of CM with 
leucine aminopeptidase (LAP, 25µg/ml), unlike CY, 
significantly increased the bioactivity of CM when compared 
to time matched controls (Figure 21) . 
These data suggesting the peptide-nature of bioactive 
component(s) of CM are supported by SDS-PAGE electrophoresis 
of enriched CM fractions. Components of CM were separated 
on a G-25 column and individual fractions (2 ml each) were 
tested for bioactivity in secretion experiments (figure 22) 
Such bioactive fractions were also loaded and 
peptide(s)separated on modified Schagger gels via SDS-PAGE. 
These gels were subsequently stained with silver. Figure 23 
shows a single peptide band in the lanes taken from 
bioactive fractions of CM. Electroelution of this band from 
similar gels also stimulated significant catecholamine 
release in secretion experiments when compared to other 
electroeluted bands (Figure 24). Mass spectroscopic 
analysis of this peptide determined the putative mass to be 
627 Da. 
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Conditioned Media Peptide Stimulates Catecholamine Release 
from Superior Cervical Ganglia Cell Cultures 
To determine if the bioactive peptide could stimulate 
catecholamine release from another secretory source, the 
sympathetic nerves, CM secretion experiments were performed 
on cells from porcine superior cervical ganglia. Cells 
exposed to CM released approximately 2 fold more 
[ 3H]norepinephrine as did those exposed to RPMI-1640 alone 
(Figure 25). This effect was concentration-dependent. 
Feedback Inhibition by Epinephrine on Mononuclear Cell 
Peptide Production 
Mononuclear cells were cultured in the presence of 
epinephrine to determine if the catecholamine could act in a 
classical negative feedback loop to inhibit further immune-
cell peptide production. Data presented in figure 26 
demonstrates that concentrations of epinephrine as low as 
lnM may inhibit release of bioactive peptide and this 
inhibition is partially reversed by ~-adrenergic blockade 
with propranolol. 
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Figure 24. Electroelution of conditioned media peptides 
reveals bioactivity is present only in peptide band of 
interest. Putative bioactive peptide (Band "B") was 
electroeluted and bioactivity tested alone; all other 
peptides were combined and tested for bioactivity in 
secretion experiments. Values are mean ± SEM from two 
triplicates on one chromaffin cell preparation (n=6). 
**=p<0.01 compared to basal chromaffin cell secretion (RPMI-
1640) or secretion due to bands > 3,000 MW using an ANOVA 
and Tukey's follow up comparisons. 
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Figure 25. Conditioned media (CM) stimulates norepinephrine 
secretion from sympathetic ganglion cells. Basal refers to 
control secretion over 90 min with serum-free RPMI-1640. 
Conditioned media was diluted with serum-free RPMI-1640. 
Values are the mean ± SEM taken from 22 different ganglion 
cell preparations (n=22). *=p<0.05 compared to all other 
bars; **=p<0.05 compared to all other bars; ***=p<0.05 
compared to all other bars. Statistics included an "ANOVA 
with Tukey's follow-up comparisons. 
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Figure 26. Feedback inhibition by epinephrine (EPI) on 
mononuclear cell (MNC) peptide production. Values are the 
mean ± SEM from six samples of one chromaff in cell 
preparation (n=6). *=p<0.05 compared to CM alone; **=p<0.01 
and ***=p<0.001 compared to CM alone; #=p<0.05 compared to 
lµM EPI+propranolol. Statistics utilized were an ANOVA with 
Tukey's follow up test. Similar results were obtained with 
MNC/EPI co-culture at concentrations between lnM and lµM. 
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D. Discussion 
Extensive documentation demonstrates that humans 
respond to both cognitive and noncognitive stimuli through a 
stress response that results in the release of epinephrine 
into the circulation (Kjaer and Secher, 1992; Webber and 
MacDonald, 1993). This increased plasma epinephrine has a 
wide array of physiologic effects including various 
modifications of immune function (Malec et al., 1989; 
Mihran-Davis et al., 1991; Rinner et al., 1992; Murray et 
al., 1993). Results of the present study provide evidence 
that immune cells are able to synthesize and release a 
novel, small molecular weight peptide which modulates 
adrenal medullary chromaffin cell epinephrine secretion. 
These findings support the concept of bidirectional 
communication between the immune system and the adrenal 
medulla and suggest a novel mechanism by which circulating 
immune cells could mediate epinephrine secretion. 
The nervous and immune systems share important 
informational molecules such as cytokines, hormones, and 
neuropeptides. These compounds serve as molecular signals 
which provide an important link between neural and immune 
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systems. Evidence is accumulating which clearly 
demonstrates that not only do the classic immune signalling 
molecules, the cytokines (i.e. TNF, IL-6, IL-1) (Haefli et 
al., 1993; Ichijo et al., 1994; Jonakait et al., 1993; 
Frieden et al., 1992; Imura et al., 1991), affect 
neuroendocrine function but also that immune cells are 
capable of synthesizing and releasing bioactive molecules 
which were previously believed to be exclusive to 
neuroendocrine systems (i.e. ACTH, ~-endorphin, CGRP) (Smith 
et al., 1981; Smith et al., 1982; Smith et al., 1983; 
Harbor-McMenamin et al., 1986; Hiestand et al.,1986). 
Expansion of this list to include a lymphoid-adrenomedullary 
interaction through an undescribed lymphocyte product is not 
surprising. 
The present study provides evidence that a single, 
novel small molecular weight peptide is released by MNC and 
stimulates adrenal medullary chromaff in cell epinephrine 
secretion to levels comparable to maximal cholinergic 
stimulation. Such conclusions are based upon evidence that 
isolated preparations of peptide retained bioactivity 
(figure 24). Evidence is also presented that excludes the 
potential impact of several extraneous variables in the 
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reported immune peptide-chromaffin cell interaction. For 
example, it is possible that the bioactive MNC peptide, 
rather than stimulating regulated catecholamine exocytosis, 
could have altered chromaffin cell integrity leading to the 
leak of catecholamine from cell cultures over the ninety 
minute CM incubation. Lactate dehydrogenase, a cytosolic 
enzyme which would leak concurrently with catecholamine if 
cell integrity was modified, was not detected in CM after 
chromaffin cell incubation (figure 17) while significant 
catecholamine was found in this same media (figure 16) . 
Furthermore, CM-induced secretion was dependent on the 
availability of extracellular calcium (figure 18) indicating 
that CM stimulated chromaff in cell epinephrine secretion 
through specific, typical exocytotic mechanisms. 
Interestingly, the data presented here utilize conditioned 
media from MNC which were not stimulated with any mitogenic 
factors. The observed production of bioactive peptide in 
the present studies without mitogenic stimulation, however, 
is not surprising. Mechanical stimulation during isolation 
of MNC or the documented mitogenic effect of the density 
centrifugation media (Kol et al., 1983) may be a sufficient 
stimulus of the MNC for bioactive peptide production. 
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The peptide nature of the immune cell-derived molecule 
in the present study was determined using several different 
lines of evidence. Acid hydrolysis of bioactive CM 
significantly decreased the bioactivity (figure 19) 
presumably through hydrolysis of the peptide bond(s). The 
peptide nature of the molecule was also demonstrated using 
proteolytic digestion. Incubation of conditioned media with 
either carboxypeptidase Y (figure 20) or leucine 
aminopeptidase (figure 21) resulted in significant changes 
in bioactivity. However, CY digestion of CM resulted in 
incomplete inactivation while LAP treatment of CM 
significantly increased bioactivity. The incomplete 
inactivation by CY could be explained by restricted 
substrate specificity of the peptidase. CY activity has 
been shown to be limited when the amino acid to the left of 
the cleavage is glycine or asparagine or when the residue to 
the right of the cleavage site is histidine or lysine. 
Potentially, these amino acid residues may be present in the 
bioactive peptide and limit CY activity. The increased 
bioactivity of CM after LAP treatment is quite interesting 
and may provide a basis for in vivo experimentation. 
Conditioned media used in these experiments was not filtered 
155 
(Centricon, 3,000 MW cutoff) until after treatment with LAP 
was complete. The increase in bioactivity is hypothesized 
to be a result of LAP cleavage of a larger "parent" molecule 
into the small bioactive peptide. Current investigations 
are examining the possibility that endogenous LAP, known to 
be released by mononuclear cell populations (Nagaoka and 
Yamashita, 1984), could liberate bioactive peptide from a 
larger protein. 
Additional evidence indicating the peptide nature of 
the bioactive factor involved G-25 Sephadex enrichment of CM 
and modified SDS-PAGE isolation/purification. Since 
peptides in solution have increased absorbance at 206 nm, 
experiments were conducted to determine if there was a 
correlation between an increase in absorbance and 
bioactivity. Fractions were obtained from the Sephadex G-25 
column which showed increased absorbance at 206 nm as well 
as demonstrated high bioactivity (figure 22) . Peptide-
enriched fractions of CM were then analyzed using gel 
electrophoresis. Separation of peptide(s) using a modified 
Schagger gel stained with silver clearly show the presence 
of a small peptide (figure 23). Biological activity of 
samples removed from similar gels by electroelution revealed 
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that only fractions containing this and no other protein 
band(s) stimulated significant catecholamine secretion from 
primary chromaffin cell cultures (figure 24) . 
Interestingly, CM peptide also stimulates catecholamine 
release from in vitro sympathetic ganglion cells. These 
results suggest that the peptide may also enhance 
norepinephrine release from peripheral sympathetic nerve 
terminals. These data are consistent with previously 
published research demonstrating increased norepinephrine 
release at constant nerve activity following a non-cognitive 
stimuli (endotoxin) (Jones et al., 1994). Additionally, 
epinephrine was shown to inhibit mononuclear cell peptide 
release and subsequent CM bioactivity (figures 25 & 
26),thus, completing a potential physiologic axis. 
The putative immune-adrenal medullary axis described in 
these studies may have several important clinical 
implications. Early in this century, Hans Selye noted that 
"diverse noxious agents" (stressors) produced nonspecific 
events that "sick people" share in common. These "noxious 
agents" included both physical agents (non-cognitive 
stimuli; i.e. viruses, bacteria, tumors) and emotional 
factors (cognitive stimuli) . The immune-derived peptide 
157 
described in these studies may be one potential mechanism by 
which non-cognitive stimuli elicit the release of the stress 
hormone epinephrine. An increased systemic epinephrine in 
response to peptide would be beneficial during sickness 
supporting the hypermetabolism of fever by alterations in 
metabolic and cardiovascular function. Acute elevations in 
epinephrine are also associated with enhanced immune 
function (Murray et al., 1993; Sanders and Munson, 1985) 
which would be equally advantageous in combatting illness. 
Prolonged elevation of plasma catecholamine, however, has 
been shown to compromise immune function and, thus, would be 
detrimental (Malec et al., 1989; Mihran-Davis et al., 1991; 
Rinner et al., 1992; Murray et al., 1993). These studies 
suggest that increased epinephrine release as in response to 
bioactive peptide may negatively feedback on cells of the 
immune system and thus prevent further production of 
bioactive peptide. Removal of the peptide stimulus would 
limit further epinephrine secretion and regulate this 
immune-neuroendocrine axis. 
The results of the present study provide further 
evidence for a physical link between the manifestations of 
stress and the immune system. These results also add to the 
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growing body of literature describing neuroendocrine-immune 
interactions and the potential importance of bidirectional 
communication between these systems in maintaining 
homeostasis. Potentially, the disruption of this putative 
immune-adrenal medullary axis may be a component of the 
pathophysiology of various chronic disease states. 
Understanding the capacity of the immune system to respond 
to a stressor through a compensatory mechanism and possibly 
alter the stress response itself via signalling molecules 
(e.g. bioactive peptide) may be useful in predicting disease 
onset and outcome. 
CHAPTER VII 
CHROMAFFIN CELL EPINEPHRINE SECRETION MEDIATED BY A 
MACROPHAGE PEPTIDE: THE ROLE OF ENDOTOXIN 
A. Introduction 
The importance of stress in the etiology and prevention 
of disease is becoming increasingly evident as research in 
this area progresses (Sheridan et al., 1994). Traumatic 
injury, hemorrhage, as well as infection and its sequelae 
are known to create a severe stress on the body. A tightly 
regulated inflammatory/immune response to these types of 
stress provides protection from invading pathogens, limits 
injury, and promotes healing. However, in some patients 
this response is not regulated and leads to an uncontrolled 
systemic response commonly ref erred to as the systemic 
inflammatory response syndrome (SIRS) . SIRS, which may 
occur in the presence or absence of infection, is manifest 
by changes in white blood cell (WBC) count (>12,000 
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cells/mm3 or< 4,000 cells/mm3 ) and maturity (> 10% immature 
bands), changes in body temperature (> 38° C or< 36° C), 
tachycardia, and tachypnea (Secor, 1994). Since the 
catecholamines, epinephrine and norepinephrine, have been 
shown to have profound effects on the cardiopulmonary system 
as well as on immune function, the marked elevations of 
plasma catecholamine that occur in response to stress may 
play an integral role in the onset and progression of SIRS. 
Catecholamines are well recognized to be released by both 
the sympathetic nervous system (mainly norepinephrine) and 
the adrenal medulla (epinephrine) during a stress response 
such as in trauma, hemorrhage or infectious challenge. 
While epinephrine secretion from the adrenal medulla is 
typically attributed to neural stimulation of medullary 
chromaffin cells, recent findings suggest that an immune 
cell-derived peptide released from mononuclear cells may 
also stimulate the secretion of medullary catecholamines 
(Jones et al., 1993). The present study was undertaken to 
test the possibility that endotoxin, a molecule which can 
induce SIRS, may stimulate the production/release of 
bioactive peptide from immune cells. Catecholamine 
secretion in response to endotoxin-induced release of the 
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immune cell-derived peptide may play a role in the altered 
cardiopulmonary and immune system function observed during 
SIRS and subsequent shock states. 
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B. Materials and Methods 
Primary Cultures of Chromaffin Cells 
Isolation and Culture: Adult bovine adrenal glands were 
used for chromaff in cell isolation according to the overall 
procedure as described by Dahmer et al., (1990). In brief, 
adrenal glands were perfused with collagenase, incubated at 
37°C and medullary tissue removed for further digestion. 
Digested cells were washed, counted, and viability 
determined with trypan blue staining (>98% in all 
preparations) . Purity was assessed using neutral red as 
described by Role and Perlman (1980) and was >92% in all 
cultures. Cells were plated on collagen-coated 24-well 
plates at a density of 3 X 10 5 cells per cm2 and media 
(Dulbecco's Minimum Essential Media, F12, growth inhibitors, 
antibiotics, 10% FBS) was changed after the first day and 
then as needed to maintain normal pH. 
In vitro Model of Catecholamine Secretion: Basic 
secretion experimental protocols are those described by 
Dahmer et al., (1990). In brief, growth media was removed 
and replaced with either conditioned media (90 min 
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incubation), RPMI-1640 (90 min, incubation), modified 
balanced salts solution (DMEM, 90 min incubation), or 
secretagogue in modified balanced salts solution (DMEM, 10 
min incubation) . After incubation, media was removed and 
saved. Catecholamine content in these samples represents 
either that stimulated by conditioned media, 
spontaneous/basal secretion (RPMI,salts solution with or 
without ETX/PHA), or that stimulated by a known 
secretagogue. Cells are then lysed by lM perchloric acid 
and acid was saved to determine the remaining epinephrine 
content of the cells. Total epinephrine secreted into the 
media was calculated from the sum of the individual 
contents. Percent chromaffin cell secretion was calculated 
by dividing the amount secreted by the total. Secretion 
experiments were routinely done in triplicate using three 
separate wells on any one plate which were derived from the 
same adrenal gland. Replicates of separate triplicate 
determinations were made on cells from different chromaff in 
cell preparations. Analysis of epinephrine was accomplished 
with HPLC using electrochemical detection. Mobile phase 
contained O.lM monochloroacetic acid with O.SmM EDTA and 
1.0rnM sodium octyl sulfate adjusted to pH 3.0. Acetonitrile 
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was added at 15ml/L. A BAS Liquid Chromatography System 
including an LC 4C amperometric detector and glassy carbon 
electrode was used in all analyses. 
Primary Cultures of Mononuclear Cells from Spleen 
Whole bovine spleen was obtained from a local slaughter 
house. Inner spleen tissue, which includes both red and 
white pulp, was dissected out, cut into small pieces and 
forced through wire mesh in salts solution at room 
temperature. Crude cell suspensions were layered on density 
gradient media (Lymphoprep) , centrifuged and then separated 
cells were removed and washed. Isolated cells were 
transferred to flasks with RPMI-1640 media containing no 
serum/growth factors. Macrophage/monocyte populations were 
isolated from other splenocytes based on 1 hour adherence to 
plastic in culture flasks at 37° C. Purity of cultures was 
determined by Wright-Giemsa staining and non-specific 
esterase activity. Cultures were either stimulated with LPS 
(S. enteritidis,lµg/ml) or phytohaemagglutinin (PHA, 
SOµg/ml) or left unstimulated. The growth media was 
isolated from the cells and either used promptly or frozen 
(-20°c) after at least 24 hours of culture. 
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Peptide Purification and Isolation 
G-25 Sephadex Column Gel Filtration: G-25 
Sephadex beads (10 g) were combined with 30 ml deionized 
water and equilibrated for 8-10 hours. This volume was 
poured into a 2 cm column which was attached to a continuous 
perfusion pump and equilibrated with Phosphate Buffered 
Saline (PBS, pH 7.2). A 2 ml by-pass loop connected to the 
column was used to introduce conditioned media onto the 
column with an injection valve. Blue Dextran (MW 2Xl0 6 ) 
provided a measure of the void volume and potassium chromate 
(MW 194) was used to determine total volume. Fraction 
collection (2 ml each) began when the void volume was eluted 
and continued until the total volume was removed from the 
beads. Elution of peptide was determined by monitoring 
absorbance at 206 nm as the effluent came off the column. 
SDS-PAGE: Basic methods are similar to those described 
by Schagger and von Jagow (1987). In brief, a 20% T 
separating gel was prepared containing 3.0 M Tris (pH=8.45) 
and glycerol. This was overlaid with a 10% spacer gel, 
followed by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding 
a gel with approximate dimensions of 0.75mm X 6.5cm X 9.5cm. 
A discontinuous buffer system was utilized which included a 
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(0.2% w:v, 3 minute incubation) and ammonium sulfate (0.5% 
w:v, 3 minute incubation) were added consecutively and the 
reaction was allowed to proceed at room temperature. 
Finally, samples were incubated with an alcoholic dye base 
solution (N-1-Naphthylethylenediamine in ethanol) for 45 
minutes at room temperature. Each sample was transferred to 
a cuvette and absorbance (562nm) was read and recorded. 
Treatment of CM Fractions with LAP: The 
peptide/protein content of G-25 enriched conditioned media 
fractions were characterized using SDS-PAGE . Fractions 
were divided into groups containing the peptide of interest 
(group "B") and those containing putative parent molecule(s) 
( > 3, 000 MW, group "A") . Groups "A" and "B" were then each 
separated into samples of equal volume. These samples were 
incubated for 5 hours at 37°C either alone or with enzyme 
(LAP, 25µg/ml). After incubation, media ± enzyme was 
centrifuged through a Centricon filter (3,000 MW cutoff) to 
remove peptidase or other molecules larger than 3,000 MW. 
Media was either used promptly in secretion experiments or 
frozen ( -2 o0c) . 
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C. Results 
ETX enhances bioactivity of conditioned media {CM). 
Mononuclear cells isolated from bovine spleen were 
cultured 24h in the presence of either ETX (S. enteritidis, 
1 µg/ml) or phytohemagglutinin (50 µg/ml) . Media was 
harvested, filtered (Centricon) to remove all molecules 
greater than 3,000 MW, then used in secretion experiments. 
While PHA in culture had no significant influence on CM 
bioactivity, the presence of ETX in splenic MNC cultures 
significantly enhanced CM bioactivity (Figure 27) . This 
enhanced chromaff in cell epinephrine release in response to 
ETX-stimulation, presumably, was due to increased 
synthesis/release of bioactive peptide. 
Bioactivity in unstimulated cell cultures come from T and/or 
B cell populations. 
To determine the mononuclear cell population(s) which 
significantly contributed to CM bioactivity in non-
mitogenically challenged cell cultures, the mononuclear cell 
populations were divided based on adherence to plastic and 
their CM harvested after 24 hours. Purity of these cultures 
was assessed using Wright-Giemsa and a non-specific esterase 
stain and determined to be > 90%. CM from the nonadherent T 
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Figure 27. Endotoxin (ETX) stimulates an increase in 
conditioned media (CM) bioactivity. Basal secretion in 
serum-free RPMI-1640 ranged from 2-5~ of total cell content 
in all experiments. Results are presented as the mean ± SEM 
taken from triplicates of one chromaff in cell preparation 
(n=3) for each bar. ***=p<0.01 compared to CM using an 
ANOVA and Tukey's follow up test. Similar results were 
obtained with other chromaffin cell preparations. 
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Figure 28. Nonadherent cell population(s) are the source of 
bioactivity in non-mitogenically challenged cell cultures. 
Basal secretion (serum-free RPMI-1640) ranged from 2-5% in 
all experiments. Values represent the mean ± SEM from 3 
different spleen preparations. **=p<0.001 compared tu CM 
from unseparated MNC cultures using an ANOVA followed by 
Tukey's comparisons. 
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cell and B cell populations had significantly greater 
bioactivity (figure 28) than adherent cell CM from 
monocyte/macrophage cell types. 
ETX stimulates monocyte/macrophage peptide production. 
Mononuclear cell populations were divided based on 
adherence to plastic then cultured either in the presence or 
absence of ETX (S. enteritidis, lµg/ml) or PHA (SOµg/ml). 
Neither ETX nor PHA significantly altered CM bioactivity 
from nonadherent cell populations (figure 29) . Adherent 
monocyte/macrophage CM bioactivity, however, significantly 
increased after 24 hour culture with ETX (figure 29). This 
enhanced bioactivity could not be attributed to the action 
of ETX on chromaffin cell cultures. 
SDS-PAGE analysis of ETX stimulated cultures shows bioactive 
band present only in stimulated monocyte/macrophage 
cultures. 
To determine if bioactive peptide was present in 
conditioned media from ETX-treated and non-treated 
monocyte/macrophage cell cultures, purified CM peptides from 
these cultures were separated using SDS-PAGE. Each gel also 
included lanes containing G-25 enriched bioactive peptide 
which had been previously characterized for reference 
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Figure 29. Endotoxin (ETX) stimulates significant increases 
in bioactivity of monocyte/macrophage conditioned media 
(CM) . Values presented are the mean ± SEM from 2 different 
MNC cultures. Secretion experiments were performed in 
triplicate on 2 chromaffin cell preparations (n=6) . Basal 
chromaffin cell secretion (serum-free RPMI-1640) ranged from 
2-4%" in all experiments. Basal secretion was unaltered by 
the addition of ETX or PHA (see graph). ##=p<0.01 compared 
to non-stimulated monocyte/macrophage CM; **=p<0.01 compared 
to unstimulated, unseparated CM. Statistics utilized an 
ANOVA followed by Tukey's comparisons. 
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Lane 1 2 3 4 5 
Figure 30. Endotoxin (ETX) stimulates the release of a 
novel, bioactive peptide from monocyte/macrophage 
populations. Samples in each lane are: Lane 1= monocyte (-
) ETX, fractions MW >3,000; Lane 2=monocyte (-) ETX, 
fractions MW <3,000; Lane 3=enriched peptide isolated from 
total mononuclear cell cultures; Lane 4=monocyte (+) ETX, 
fractions MW>3,000; Lane 5=monocyte (+) ETX, fractions MW 
<3,000. The previously characterized bioactive peptide is 
only detectable in media from monocytes cultured in the 
presence of ETX (Lane 5) . 
-ETX +ETX Fold Increase 
Conditioned Media 3.45 +/- .2 7.6 +/- .4 (***) 2.2 
Macrophage CM 3.24 +/- .6 7.32 +/- 1.3 (**) 2.3 
T/B Cell CM 9.36 +/- .3 9.035 +/- .7 1.0 
Mouse Serum 9.2 +/- .3 13.8 +/- .2 (##) 1.5 
Table 1. Leucit¥: aminopeptidase (LAP) activity is significantly increased in ETX-
treated macrophage cultures and endotoxic mouse serum .. 
Data presented are leudne aminopeptidase activity exp~ as units per million cells. 
CM= conditioned media 
***=p<0.001 compared to CM(-) ETX 
**=p<0.01 comapred to Macrophage(-) ETX 
##=p<0.01 compared to normal serum (-) ETX 
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purposes. While the bioactive peptide band was not present 
in non-bioactive CM from unstimulated monocyte/macrophage 
cultures, the ETX-challenged monocyte/macrophage CM did 
contain the bioactive peptide (figure 30) . 
Increased leucine aminopeptidase activity correlates with 
increased CM bioactivity. 
ETX-challenge of both the total MNC CM and the adherent 
cell CM increased the LAP activity of these cultures 
approximately 2 fold (table 1) . Increased LAP activity in 
ETX-treated cultures was associated with significantly 
increased bioactivity compared to non-treated cultures. 
Nonadherent cell CM, which demonstrated significant 
bioactivity prior to stimulation, had significant LAP 
activity both in the presence or absence of ETX. The LAP 
activity of mouse serum also increased after ETX-challenge 
and was approximately 1.5 fold greater than control. 
LAP treatment of non-bioactive CM peptides >3,000 MW yields 
bioactivity. 
G-25 Sephadex enriched fractions of CM peptides were 
separated into two groups. Group "A" contained all CM 
peptides greater than 3,000 MW while group "B" contained 
only the bioactive peptide. While the bioactivity of group 
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"B" (bioactive peptide) was unaltered by LAP treatment, LAP 
digestion of group "A" yielded significant bioactivity in a 
previously non-bioactive media (figure 31) . 
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Figure 31. LAP treatment yields bioactivity from non-
bioactive CM proteins (>3,000 MW). G-25 purified fractions 
of CM were divided based on peptide content. Fractions 
containing bioactive peptide were pooled and labelled "B" 
while others with peptides/proteins >3,000 MW were combined 
and labelled "A". Values given are the mean± SEM from two 
triplicates from one chromaffin cell preparation (n=6) . 
**=p<0.01 compared to group "B" ± LAP using an ANOVA with 
Tukey's follow-up comparison. Similar results were obtained 
in two other chromaffin cell preparations. 
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D. Discussion 
The inflammatory/immune response normally protects the 
body and limits the extent of injury. In the setting of 
critical illness and/or severe injury, however, regulation 
of this response is often lost for reasons that remain to be 
elucidated. An uncontrolled inflammatory/immune response 
combined with infection, inflammation, and/or ischemia often 
leads to the development of the Systemic Inflammatory 
Response Syndrome (SIRS) , which is frequently associated 
with the development of septic shock, multiple organ 
dysfunction (MODS), and other complications of critical 
illness. Although multiple mediators are involved in the 
inflammatory/immune response, one of the most influential 
mediators of SIRS and subsequent septic shock appears to be 
endotoxin (Beutler, 1993). Endotoxin, through activation of 
phagocytic cells (e.g. the macrophage), stimulates the 
production and release of potent inflammatory/immune 
mediators which include tumor necrosis factor (TNF) and 
interleukin-1 (IL-1). Elevation of these factors leads to 
complications such as endothelial damage and metabolic 
abnormalities which are associated with SIRS. 
Interestingly, these same cytokines have been shown to 
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modify neuro/endocrine function via the hypothalamic-
pituitary-adrenal axis (Imura et al., 1991; Haefli et al., 
1993). Additionally, IL-1 has been shown to enhance 
sympathetic nerve activity (Ichijo et al., 1994), modify 
neuronal gene expression of substance P (Jonakait, 1993), 
and is synthesized and released by cultured sympathetic 
neurons (Frieden et al., 1992). Since the full 
manifestation SIRS and the sequelae that follow appears to 
be dependent on both inflammatory as well as hormonal 
mediators (Secor, 1994), the ability of immune-derived 
signalling molecules (TNF, IL-1 or even CM peptide) to 
modulate hormone release may have important clinical 
implications in SIRS or septic shock . 
Among the hormonal mediators which contribute to 
SIRS/septic shock are the catecholamines, especially 
epinephrine - a hormone released from the adrenal medulla. 
The catecholamines have profound effects on cardiovascular 
function, cellular metabolic activity as well as immune cell 
function (Kjaer and Secher, 1992; Webber and Macdonald, 
1993; Plaut, 1987). Recent evidence suggests that immune 
cells, however, may not only respond to changes in plasma 
catecholamine but also may modulate the release of 
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catecholamine from the adrenal medulla via a small peptide 
(Jones et al., 1993). This peptide-induced medullary 
catecholamine release may be an additional pathway by which 
plasma catecholamine is elevated during SIRS and subsequent 
septic shock. 
The current study demonstrates that ETX, an influential 
mediator of SIRS/sepsis, enhances production of this peptide 
from mononuclear cell populations. Media (conditioned 
media, CM) taken from ETX-challenged MNC stimulated 
significantly more chromaff in cell epinephrine secretion 
that did CM from unstimulated or PHA-stimulated MNC cultures 
(figure 27) . Although T and/or B cell populations are the 
primary source of peptide in cell cultures not stimulated 
with ETX (figure 28), ETX appears to stimulate bioactivity 
of CM by inducing peptide release from monocyte/macrophage 
cell populations (figures 29 & 30). Previously we have 
demonstrated that treatment of CM with the exopeptidase 
leucine aminopeptidase (LAP) significantly increased CM 
bioactivity (Jones et al, 1995). Interestingly, ETX has 
been shown to increase protease secretion from macrophage 
populations (Nathan, 1987) . Equally noteworthy is the fact 
that monocyte/macrophages synthesize and release LAP 
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(Nagaoka and Yamashita, 1984; Becher, 1984). The premise of 
these studies was that ETX-challenge stimulated 
monocyte/macrophage LAP release and this LAP was cleaving 
some larger protein/peptide to liberate bioactive peptide in 
these cultures. Data presented in table 1 showing an 
increased LAP activity in ETX-treated monocyte/macrophage 
and total mononuclear cell cultures support this hypothesis. 
Potentially, this LAP may cleave the bioactive peptide from 
a larger parent compound released from the mononuclear 
cells. This idea is also supported by the data in figure 31 
which demonstrates that previously non-bioactive CM peptides 
(>3,000 MW) exhibit significant bioactivity after 5 hour LAP 
treatment. 
Much like TNF and IL-1, the bioactive peptide may be an 
additional signalling molecule released from ETX-stimulated 
monocyte/macrophage populations which is able to modulate 
hormone release. Production of this peptide via proteolytic 
cleavage of a larger parent compound is not surprising. 
Examples of enzymatic conversion of a promolecule to its 
bioactive compound include plasminogen activator, a serine-
type proteinase, which converts inactive plasminogen to 
plasmin by cleaving a single peptide bond (Dano et al., 
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1985; Reich, 1978). Proteolytic cleavage of several 
promolecules are also involved in the activation of the 
complement cascade (Medicus et al, 1976; Mueller-Eberhard, 
1981), an integral part of host defense against infections. 
Endotoxin stimulation of monocyte/macrophage populations may 
stimulate the synthesis and release of both peptidases (e.g. 
LAP) and the parent molecule. These peptidases may then 
cleave the parent molecule at the amino terminus thereby 
liberating bioactive peptide which would stimulate adrenal 
medullary catecholamine release. Since LAP is an 
exopeptidase (i.e. LAP hydrolyzes peptide bonds ar or near 
the amino-terminus of the peptide), it is highly unlikely 
that LAP is liberating the bioactive peptide from the parent 
molecule. However, highly purified preparations of LAP have 
been shown to have traces of contaminating endopeptidases 
(Royer and Andrews, 1973; DeLange and Smith, ) . 
Potentially, endopeptidase contaminants of the LAP utilized 
in these experiments may be responsible for clevage of the 
parent compound and liberation of bioactive peptide. 
The implications and potential applications of this 
knowledge are many fold. Since the imposition of a stressor 
(e.g. injury/infectious challenge) disrupts homeostasis, it 
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is important to understand how the immune system may 
compensate and function during such times of stress. In 
addition, the ability of the immune system to directly 
modify the stress response through epinephrine secretion may 
prove invaluable in understanding homeostatic mechanisms. 
As suggested by a growing body of literature, systems 
previously believed to be essentially autonomous (i.e. 
immune system) are now considered to share informational 
molecules such as cytokines, hormones, and neuropeptides 
with other (neural/endocrine/neuroendocrine) systems. 
Further evidence delineating other structural or functional 
connections between these systems, such as the presently 
described CM peptide, only strengthens the concept of 
systems interdependence and may potentially aid in 
understanding systemic dysfunction. Once the homeostatic 
role of signalling molecules are elucidated, recognizing the 
functional role of these molecules in a pathophysiology 
(e.g. SIRS/sepsis) may provide a basis for therapeutic 
intervention. 
CHAPTER VIII 
SUMMARY AND CONCLUSIONS 
The present dissertation study further identified and 
characterized a small molecular weight (<3,000) peptide 
which stimulates adrenal medullary catecholamine secretion 
to levels comparable to maximal cholinergic stimulation. 
The first project in this study addressed the role of 
calcium in the signal transduction pathway of peptide-
stimulated chromaffin cell secretion. Information obtained 
in these studies demonstrated that the calcium-dependent 
signalling mechanisms of bioactive peptide are similar to 
other known peptide secretagogues. The second project 
focused on the mononuclear cell source of this peptide. The 
data provided by these experiments may provide insight to 
the function of the peptide in local immunoregulation or in 
intersystems communication. The third project characterized 
the peptide-nature and other properties of the molecule as 
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well as isolated the bioactive peptide. This project was 
essential in obtaining a putative molecular weight, as well 
as potentially sequencing the isolated molecule. Finally, 
the fourth project examined a potential role for bioactive 
peptide in endotoxicosis and subsequent shock states. These 
final studies suggested a role for the peptide in vivo. 
As can be integrated from the present study as well as 
previous works, a schematic representation of the 
significance of immunomodulation of adrenal medullary 
catecholamine release is presented in Figure 32. In 
response to non-cognitive stimuli, a large precursor 
molecule is released from mononuclear cell populations; 
specifically CD4+ T cells, B cells, and endotoxin-challenged 
monocyte/macrophage populations. Endogenous proteases (e.g. 
leucine aminopeptidase/LAP) cleave the bioactive peptide 
from this "parent" compound. In circulation, this peptide 
may reach the adrenal medulla and stimulate medullary 
chromaffin cell epinephrine secretion. The subsequent 
increase in plasma catecholamine may then feedback on the 
mononuclear cell populations to inhibit further peptide 
production. An extension of this working model may be found 
in figure 33. Since many regulatory molecules previously 
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thought to be limited to the the immune system (e.g., IL-1, 
IL-6, TNF) are now known to be expressed by both (Krieger, 
1983; Plaut, 1987; Carr and Blalock, 1991) it is possible 
that the parent molecule of conditioned media peptide may 
also be produced and processed in the CNS or in peripheral 
neuroendocrine structures. This provides a second potential 
source for conditioned media peptide modulation of 
catecholamine release during a typical stress response. A 
second possibility, as demonstrated in figure 33, is that 
CM-peptide may serve an autocrine/paracrine function and 
modulate cells of the immune system. As is depicted in the 
figure, studies have shown that peptide signalling molecules 
(e.g. ACTH, the endorphins, CG) common to both immune and 
neuroendocrine structures have immunoregulatory properties 
and are speculated to regulate immune function in vivo 
(Blalock, 1992, Blalock, 1994, Weigent et al., 1990) The 
immune cell-derived peptide characterized in this 
dissertation study may also serve in some immunoregulatory 
capacity. 
A final schematic representation constructed from 
information provided in this dissertation study, in 
combination with current information in the literature, is 
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presented in Figure 34. This figure illustrates the 
potential calcium-regulated signalling mechanism of peptide-
induced secretion. Bioactive peptide, similar to other 
known peptide-secretagogues (i.e. bradykinin and angiotensin 
II), binds to its cell surface receptor on the chromaffin 
cell. This receptor is coupled to a second messenger 
system, possibly via phophoinositide metabolism, which 
stimulates release of calcium from intracellular stores as 
well as extracellular calcium influx. Temporally, this rise 
in intracellular calcium in response to peptide would reach 
a peak quite quickly due to calcium influx as well as 
release from internal stores. A secondary, long term phase 
increase in internal calcium concentrations resulting from 
the influx of extracellular calcium would follow. 
Evidence provided in this dissertation study in support 
of figures 32, 33, and 34 are enumerated as follows. The 
first project evaluated the signal transduction mechanism of 
this peptide. Specifically, the study utilized 
pharmacologic agents as well as a fluorescent dye indicator 
to address the role of calcium in peptide-induced secretion. 
Summary of results from the first project: 
1. Extracellular calcium is essential for peptide-induced 
secretion. 
2. Release of calcium from intracellular stores are not 
required for peptide induced-secretion. 
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3. Voltage-gated calcium channel blockers do not completely 
inhibit secretion in response to peptide stimulation. 
4. The rise in intracellular calcium in response to peptide 
is biphasic. 
5. Peptide-induced increase in intracellular calcium is due 
to release from internal stores as well as influx from the 
external environment. 
Conclusions drawn from the first project: 
1. The calcium dependence of peptide-induced secretion is 
similar to other known peptide secretagogues. 
2. The biphasic, long term elevation in intracellular 
calcium may be one of the reasons for the substantial 
chromaff in cell epinephrine secretion, comparable to maximal 
cholinergic stimulation, in response to peptide. 
The second project of this dissertation study 
identified potential mononuclear cell source(s) of bioactive 
peptide. Specifically, mononuclear cell populations were 
separated utilizing cell-specific characteristics and 
immunologic methods. The presence of peptide in the 
conditioned media from each population was assessed using 
bioassay and polyacrylamide gel electrophoresis. 
Summary of results from project two: 
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1. The bioactive peptide is a product of viable mononuclear 
cells. 
2. T helper (CD4+) cell population conditioned media is 
significantly bioactive. 
3. B cell populations produce bioactive peptide. 
Conclusions from the second project: 
1. Since the peptide is a product of viable cells in vitro 
it may be an immune cell product in vivo. 
2. T helper cells release the majority of peptide, although 
B cells are a potential source. 
The third project further isolated and characterized a 
single mononuclear cell peptide which possessed the majority 
of conditioned media bioactivity. Specifically, conditioned 
media was tested using several enzymatic and proteolytic 
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tests to determine the nature of the bioactive factor(s). 
Bioactive component(s) were further separated and isolated 
using SDS-PAGE. 
Summary of results from the third project: 
1. Lactate dehydrogenase is not present in conditioned media 
after exposure to bovine chromaff in cells while significant 
amounts of catecholamine are in the media. 
2. Calcium is an essential component of peptide-induced 
secretion. 
3. Acid hydrolysis of conditioned media significantly 
decreased bioactivity. 
4. Peptidase treatment altered bioactivity of conditioned 
media. 
5. SDS-PAGE of enriched fractions of conditioned media 
revealed the most bioactive fractions contained a single 
peptide band. 
6. The single peptide band, electroeluted from the gel, 
exhibited bioactivity whereas other conditioned media 
peptides did not. 
7. Conditioned media peptide stimulates norepinephrine 
release from cultured sympathetic ganglion cells. 
8. Mononuclear cell co-culture with epinephrine 
significantly reduces bioactivity of conditioned media. 
Conclusions from project three: 
1. Conditioned media-induced secretion is a discrete 
exocytotic event. 
2. Bioactive factor in conditioned media is a peptide. 
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3. The majority of conditioned media bioactivity is due to a 
single, small molecular weight peptide (627Da) . 
4. Conditioned media peptide may stimulate both adrenal 
medulllary epinephrine secretion as well as norepinephrine 
release from sympathetic nerve terminals. 
5. Feedback regulation is suggested by significant decreases 
in CM bioactivity subsequent to mononuclear cell challenge 
with physiologically relevant concentrations of epinephrine. 
The final project of this study addressed the potential 
role of this peptide in the long-term elevation of plasma 
catecholamine observed in endotoxicosis. Specifically, in 
vitro techniques were utilized to determine conditioned 
media bioactivity and identify the presence of peptide in 
mononuclear cell cultures before and after challenge with 
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endotoxin. Significant bioactivity and presence of peptide 
were then correlated with the activity of a metalloprotease, 
leucine aminopeptidase. 
Summary of results from the fourth project: 
1. Conditioned media from monocyte/macrophage populations 
stimulates chromaff in cell epinephrine secretion only after 
challenge with endotoxin. 
2. SDS-PAGE analysis of monocyte/macrophage conditioned 
media revealed that peptide band is present only in 
endotoxin-treated cultures. 
3. Leucine aminopeptidase activity increased in endotoxin 
treated conditioned media from total mononuclear cell 
cultures and in monocyte/macrophage cultures. 
4. Leucine aminopeptidase treatment of non-bioactive 
conditioned media peptides (MW>3,000) led to significant 
bioactivity. 
Conclusions drawn from project four: 
1. Monocyte/macrophage populations may be an important 
source of peptide in infectious/shock states. 
2. Endotoxic stimuli may liberate proteases which cleave 
bioactive peptide from a non-bioactive parent molecule. 
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3. Endotoxin-liberated peptide may comprise part of the non-
neurogenic release of catecholamine and may play a role in 
the long-term elevations in plasma catecholamines observed 
in septic shock. 
For centuries a link has been noted between stressful 
periods in life, as a result of cognitive and non-cognitive 
factors, and illness (Selye, 1936; Selye, 1975; Kort, 1994). 
While many mechanisms are possible, a growing body of 
literature indicates that stress-induced dyshomeostasis is 
largely a result of interactions between the immune and 
neuroendocrine systems (Sheridan et al., 1994) Hormonal 
mediators of the stress response (i.e. the catecholamines 
and the glucocorticoids) have been shown to have profound 
effects on immunologic function. Both the corticosteroids 
and the catecholamines inhibit many functions of leukocytes 
and alter their trafficking patterns. In addition, these 
stress hormones modulate production of various cytokines and 
inflammatory mediators as well as modulate the effects of 
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these substances at various target tissues (Chrousos and 
Gold, 1992). 
Interestingly, recent evidence suggests that not only 
do the stress hormones effect immunologic function, but also 
many immune-derived signalling molecules may modulate stress 
hormone release. For instance, cytokines such as 
interleukins-1 and -6 (IL-1, IL-6) and tumor necrosis 
factor (TNF) are all potent modulators of the hypothalamic 
pituitary adrenal axis (Imura et al., 1991; Haefli et al., 
1993 ) . Additionally, IL-1 has been shown to enhance 
sympathetic nerve activity (Ichijo et al, 1994). Finally, 
numerous endogenous, potentially immune-derived substances 
such as histamine (Bunn and Boyd, 1992), bradykinin (Owen et 
al., 1989), and angiotensin II (Powis and O'Brien, 1991) may 
stimulate catecholamine release from the adrenal gland. 
The present dissertation study isolated and 
characterized a single, novel mononuclear cell-derived 
peptide which stimulates adrenal medullary catecholamine 
secretion to levels comparable to maximal cholinergic 
stimulation. This peptide, derived from T helper, B cell 
and endotoxin activated monocyte/macrophage cell 
populations, stimulates chromaffin cell epinephrine 
195 
secretion in a calcium dependent manner similar to other 
known peptide secretagogues. Furthermore, in vitro evidence 
suggests a role for this peptide in the elevation of plasma 
catecholamines seen in endotoxicosis. Finally, polyvalent 
antisera was obtained in this study which significantly 
inhibited conditioned media bioactivity (See Appendix) 
indicating the presence of an antibody specific for CM-
peptide. This antisera was also used to develop methods for 
an enzyme-linked immunoabsorbent assay (ELISA) which may be 
utilized in future experimentation to screen for bioactive 
peptide (See Appendix) . 
Based on data obtained from the current work, further 
studies could be developed to determine the physiologic 
significance this peptide. The most important of these 
would be to sequence the isolated peptide as well as its 
parent molecule. Such information would provide a basis for 
production of peptide in large quantities to use in 
controlled in vitro and in vivo experimentation. For 
example, in vitro experiments could utilize pure peptide to 
assess the immunomodulatory properties, if any, of the 
molecule. Pure peptide may also be used to study, in 
greater detail, the calcium-dependent signal transduction 
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mechanism of the peptide. This sequence data could also be 
utilized to develop a Radioimmunoassay (RIA) . An RIA is 
often utilized to quantitate small molecular weight peptides 
(e.g., bioactive peptide) since these small molecules lack 
the two non-overlapping epitopes required to perform 
commercially utilized sandwich ELISAs. This RIA, in 
conjunction with the already developed compeptitive ELISA, 
may be utilized in prospective whole animal studies to 
screen for and quantitate peptide in either the sera or 
various other compartments of animals during immunologic 
challenge. RIA/ELISA data which indicated that the peptide 
concentration increased in an animal population in response 
to a specific stimuli (e.g. endotoxin challenge) would then 
provide a basis for future in vivo experimentation. In vivo 
experimentation may include the use of anti-peptide 
antibody. Diminished plasma catecholamine in 
immunologically-challenged (e.g. endotoxin) animals treated 
with anti-peptide antibody versus endotoxic, untreated 
animals would indicate a cause-effect relationship between 
peptide and catecholamine release. Such specific action 
could be confirmed by infusing the peptide into animals and 
comparing plasma catecholamine levels to that in control 
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animals. These studies would add important new information 
as to how this peptide may play a role in homeostatic 
mechanisms. Knowledge of signalling molecules involved in 
intersystems communication and their role in homeostasis 
make therapeutic manipulation and improved patient treatment 
possible. 
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Figure 32. Potential in vivo mechanism of bioactive peptide 
production. 
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Figure 33. Extension of the current working model. 
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Figure 34. Potential calcium-dependent signal transduction 
mechanism of the bioactive peptide. 
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APPENDIX 
EVIDENCE OF A POLYCLONAL ANTIBODY 
SPECIFIC FOR BIOACTIVE PEPTIDE 
Antibodies (Ab), a family of structurally related 
glycoproteins produced/secreted by B cells, mediate the 
protective effects of humoral immunity by binding foreign 
substances referred to as antigens (Ag) . Each B lymphocyte 
produces antibody of single specificity responsible for 
recognition and targeting of a single antigen. Several 
powerful experimental techniques have been developed based 
on the specificity of antibody-antigen interaction. One of 
these techniques is the enzyme linked immunoabsorbent assay 
(ELISA) . 
The ELISA is an immunologic technique (figure 35) by 
which one can quantify antigen (e.g. bioactive peptide) 
concentrations by using an indicator molecule coupled 
covalently to an enzyme. Antigen is quantified by 
determininig the initial rate at which an enzyme converts a 
clear substrate in the solution to a colored product. 
Experiments in this study utilized anti-peptide antibody 
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with fixed amount of immobilized antigen 
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into colored product. Based on absorbance units. the intensity of the color change 
is proportional to [antigen] bound by antibody. 
Figure 35. Diagram of Enzyme Linked Immunoabsorbent Assays 
(ELISA) . 
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obtained from rabbit antisera to develop an ELISA specific 
for bioactive peptide. 
Detailed methods for antibody production and 
development of ELISA may be found in Chapter III. Briefly, 
concentrated peptide, previously characterized using SDS-
PAGE, was attatched to a 96 well assay plate and incubated 
overnight at 4°C. Although a range of pH conditions were 
tested, physiologic pH (7.4) was sufficient to provide 
adequate peptide attachment to the plate. Concurrently, CM 
peptides >3,000 MW, Keyhole Limpet Hemocyanin (KLH) 
immunogen, KLH-linked peptide, bradykinin, angiotensin II, 
and rabbit antisera (primary/1° antibody were attached to 
plate wells using similar protocol. Large molecular weight 
CM proteins/peptides were attached to plates to screen for 
the presence of parent compound"s" reactive to antibody. 
Keyhole Limpet Hemocyanin (KLH) and KLH-linked peptide were 
used since this carrier-protein complex was used to 
challenge rabbits to produce antisera. Bradykinin and 
angiotensin II, small peptides unrelated to CM-peptide, were 
used as controls to determine background and antibody cross-
reactivity. Finally, primary antibody (rabbit antisera) was 
attached to plates to ensure that the secondary (2°) 
antibody (goat anti-rabbit IgG) bound primary. 
After peptide/protein attachment, wells were washed 
(PBS/0.05~ Tween-20) and active sites blocked with 0.05% 
gelatin (room temperature, 2h). Wells were washed again 
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(PBS/Tween solution) then serial dilutions of rabbit 
antisera (50, 100, 250, 500, 1000, 5000 fold) were added to 
the wells and allowed to incubate (lh, 37°C; overnight, 
4°C) . To measure the amount of specifically bound antisera, 
each well was incubated with horseradish peroxicase (HRP) 
coupled secondary antibody (goat anti-rabbit antibody, 
Accurate Chem. Corp., Westbury, NY) for 2h at room 
temperature. Wells were washed at least three times with 
PBS/Tween then 0.5ml DAB Peroxidase substrate was added. 
The reaction between the peroxidase enzyme on the 2°-
antibody and the substrate are as follows: 
Peroxidase (HRP) + H20 2 --------------> 0 2 + 2H20 
0 2 + DAB ------------> insoluble, brown-black 
precipitate 
Absorbance at 492nm was the indicator of the presence of 
reactive antibody. 
Results obtained from 12 ELISA plates all indicated the 
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presence of anti-peptide antibody in the rabbit sera. An 
example of data taken from these studies appears in table 2. 
Similar studies were performed using the slot-blot 
technique. This technique involves blotting a membrane 
(i.e. nitrocellulose) with peptide/protein which adheres to 
the membrane. The membrane is then incubated with blocking 
solution, primary antibody, and secondary antibody in a 
protocol similar to that described for the ELISA. Data from 
the slot-blot experiments strongly support results obtained 
using the ELISA. 
Interestingly, as can be seen in table 2, the antibody 
appears to bind a CM peptide/protein of MW>3,000 - a 
putative parent molecule. Limited studies utilizing Western 
blot analysis demonstrates that the antisera binds not only 
the peptide but also a larger CM peptide/protein. These 
same peptide bands are not detected by preimmune sera, 
further supporting antibody specificity. 
" "A 
"B 
AII/B 
Aprotini 
" 
:R 
n 
1:100 
0.348 
0.289 
0.218 
0.111 
Primary Antibody 
(dilutions) 
1:500 
0.233 
0.200 
0.212 
0.105 
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Preimmune Serum Secondary 
(dilutions) Ab Alone 
1:1000 1:100 1:500 1:1000 
0.212 0.231 0.212 0.121 
0 152 0 176 0.146 0.146 
0.200 0.196 0.214 0.161 
0.103 0.102 0.122 0.123 
Table 2. Enzyme Linked Immunoabsorbent Assay (ELISA) results 
indicate the presence of antibody to a bioactive peptide 
epitope. "A"=potential parent compound(s); "B"=peptide band 
of interest; ATII/Br= Angiotensin II/Bradykinin (indication 
of background absorbance) . Results presented are absorbance 
units (492nm) from wells on a 96 well plate. Similar 
results were obtained in 11 other samples. 
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The specificity of this anti-peptide antibody was 
further confirmed using a competitive ELISA. Methods were 
similar to those described previously. In the competitive 
ELISA, however, a fixed quantity (O.lOmg peptide) was added 
to the diluted antisera prior to its addition to the wells. 
This peptide then "competed" against the peptide attached to 
the well for anti-peptide antibody. Table 3 demonstrates 
that specific binding diminished more than 80% in the 
presence of excess peptide. 
Finally, direct proof of a relevant antibody was 
obtained via secretion experiments in the presence and 
absence of anti-peptide antibody. Antisera significantly 
inhibitted secretion in response to conditioned media 
(Figure 36). This inhibition was not observed with a 
similar concentration of preimmune sera. Secretion in the 
presence of sera alone (in RPMI-1640) was not significantly 
different than basal secretion. These results indicate the 
presence of a relatively specific polyvalent antibody to CM-
peptide in immunized rabbit sera. 
"A" Fractions 
Bioactive Peptide 
KLH-Peptide 
(-)Peptide 
0.231 +/-.006 
0.212+/-.004 
0.243+/-.004 
(+)Peptide 
0.133+/-.006 
0.132+/-.002 
0.148+/-.003 
Table 3. Bioactive peptide significantly reduces antibody binding to immobilized 
peptide/parent protein. Peptide/parent compound attached to 96 well plates was 
incubated in with rabbit antisera ( 1: 100 dilution) in the presence ( +) or absence (-) of 
bioactive peptide (O. lmg). Antisera binding of immobilized peptide/protein was assessed 
according to ELISA protocol. Numbers mean absorbance ( 492nm) +/- SEM from two 
triplicate determinations (n=6). 
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Figure 36. Anti-peptide antibody significantly inhibits 
conditioned media (CM) bioactivity. Secretion experiments 
used filtered (Centricon, 3,000 MW cutoff) conditioned media 
in the presence or absence of rabbit antisera (1:100 
dilution) or preimmune sera (1:100 dilution) over a 90 
minute time course. RPMI-1640 indicative of basal 
secretion. Values presented are mean ± SEM from two 
triplicates from one chromaffin cell preparation (n=6) 
***=p<0.001 compared to CM. Comparisons were made using an 
ANOVA with Tukey's follow-up test. 
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